YOLO_HM personal page - To The Moon

YOLO_HM

YOLO_HM

No personal profile

28Follow

3Followers

0Topic

0Badge

10-30

$SUPER MICRO COMPUTER INC(SMCI)$ With the resignation from EY, it shows the corporate governance concern is real. I will stay away for now until it has been clean up. Possible to go down to $20 range.

2021-03-26

Cathie Wood herself has been bullish else she won't have invested recently.

Cathie Wood Cautions Investors Against Transacting With Bitcoin Until Tax Code Is Changed

2021-03-26

No doubt the future potential is there.

Sorry, the original content has been removed

2021-03-26

As long as it is fluctuating in a decent range, it mean good for trader.

Bitcoin's Never-Ending Bubble and Other Mysteries

2021-03-26

Short term impact meaning a good entry point for this stock will be available.

NIO: It is estimated that approximately 19,500 vehicles will be delivered in the first quarter

2021-03-19

Great news.

Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation

2021-03-19

$Kaixin Auto Group(KXIN)$ Going strong.

2021-03-18

$Kaixin Auto Group(KXIN)$ continue to hold on.

2021-03-18

$Kaixin Auto Group(KXIN)$ didn't sell when it came down to $3.15. Now is getting the reward for believing in the counter.

2021-03-16

$Kaixin Auto Group(KXIN)$ still holding on for higher.

2021-03-15

Hope they don't mess up the market again.

FOMC meeting, retail sales: What to know in the week

2021-03-15

SNDL already up a fair bit.

Sorry, the original content has been removed

2021-03-12

Closed below $50.

Coupang spikes 85% on its first day of trading

2021-03-11

Nice

Dow rises 100 points to another record, Nasdaq jumps 1.5% as tech comeback resumes

2021-03-11

Wonder what price it will start trading when debut?

Softbank-backed Coupang (CPNG) Raises $4.6 Billion in the Biggest 2021 US IPO, Valued at $60 Billion

2021-03-11

Likely

Sorry, the original content has been removed

2021-03-11

Me too

GE signs $30 billion deal for aircraft leasing unit, but investors aren’t sold on the stock

2021-03-11

Adding this to my tracking list ?.

Roblox spikes 44% on its first day of trading

2021-03-11

$Kaixin Auto Group(KXIN)$ still holding on for higher. I believe it can go to $4.50 range.

2021-03-10

?

The stimulus money isn’t going to be spent, Bank of America says, so here are the investment moves to make

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3577510395599113","uuid":"3577510395599113","gmtCreate":1614417179850,"gmtModify":1614516364884,"name":"YOLO_HM","pinyin":"yolohmyolohm","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":28,"tweetSize":48,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.09","exceedPercentage":"80.77%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.14","exceedPercentage":"80.99%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":365762240487672,"gmtCreate":1730298098561,"gmtModify":1730298102275,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$&nbsp;</a> With the resignation from EY, it shows the corporate governance concern is real. I will stay away for now until it has been clean up. Possible to go down to $20 range.","listText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$&nbsp;</a> With the resignation from EY, it shows the corporate governance concern is real. I will stay away for now until it has been clean up. Possible to go down to $20 range.","text":"$SUPER MICRO COMPUTER INC(SMCI)$ With the resignation from EY, it shows the corporate governance concern is real. I will stay away for now until it has been clean up. Possible to go down to $20 range.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":2,"link":"https://ttm.financial/post/365762240487672","isVote":1,"tweetType":1,"viewCount":1813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":356167541,"gmtCreate":1616765620383,"gmtModify":1704798577803,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Cathie Wood herself has been bullish else she won't have invested recently.&nbsp;","listText":"Cathie Wood herself has been bullish else she won't have invested recently.&nbsp;","text":"Cathie Wood herself has been bullish else she won't have invested recently.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/356167541","repostId":"1160686264","repostType":4,"repost":{"id":"1160686264","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1616764648,"share":"https://ttm.financial/m/news/1160686264?lang=&edition=fundamental","pubTime":"2021-03-26 21:17","market":"fut","language":"en","title":"Cathie Wood Cautions Investors Against Transacting With Bitcoin Until Tax Code Is Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=1160686264","media":"Benzinga","summary":"Earlier this week,Tesla Inc(NASDAQ:TSLA) announced that customers could now buy Tesla with Bitcoin (","content":"<p>Earlier this week,<b>Tesla Inc</b>(NASDAQ:TSLA) announced&nbsp;that customers could now buy Tesla with&nbsp;<b>Bitcoin</b>&nbsp;(CRYPTO: BTC), but Ark Invest's Cathie Wood isn’t so sure investors should use it as a means of payment.</p>\n<p><b>What Happened:</b>In a webcast hosted by CBOE, Wood&nbsp;said&nbsp;that those that made profits from Bitcoin’s rally may be the subject of scrutiny by the IRS.</p>\n<p>The ARK Invest founder explained, \"The IRS has something to say about this, so if you have huge gains in your bitcoin, I don't think I would bear much in the way of transactions until we get maybe some changes on the tax front.”</p>\n<p><b>Why It Matters:</b>From a tax point of view, the IRS currently treats Bitcoin and other cryptocurrencies as “property,”&nbsp;as they do stocks and bonds. As a result, when investors sell their Bitcoin for fiat currency or use it as a means to purchase another good, they could be subject to massive capital gains taxes.</p>\n<p>Capital gains on taxes on assets that have been held for less than a year are taxed the same&nbsp;as a person’s “other income,”&nbsp;while assets that are held for longer than this period would be subject to long-term capital gains taxes ranging from 15-20%.</p>\n<p>While this would make any Tesla purchases with Bitcoin somewhat unfavorable for those that bought the cryptocurrency last year, more recent investors may actually benefit from the current rules.</p>\n<p>For instance, if an investor purchased the leading cryptocurrency&nbsp;at a higher price than its current value, he or she could actually report a loss and receive a tax deduction for the value of the asset.</p>\n<p><b>Price Action:</b>After a volatile week, Bitcoin price recovered from yesterday's low of&nbsp;$50,856&nbsp;to $53,900 today. At press time, the cryptocurrency was trading at $53,223, according to data from CoinMarketCap.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Cautions Investors Against Transacting With Bitcoin Until Tax Code Is Changed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Cautions Investors Against Transacting With Bitcoin Until Tax Code Is Changed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-03-26 21:17</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Earlier this week,<b>Tesla Inc</b>(NASDAQ:TSLA) announced&nbsp;that customers could now buy Tesla with&nbsp;<b>Bitcoin</b>&nbsp;(CRYPTO: BTC), but Ark Invest's Cathie Wood isn’t so sure investors should use it as a means of payment.</p>\n<p><b>What Happened:</b>In a webcast hosted by CBOE, Wood&nbsp;said&nbsp;that those that made profits from Bitcoin’s rally may be the subject of scrutiny by the IRS.</p>\n<p>The ARK Invest founder explained, \"The IRS has something to say about this, so if you have huge gains in your bitcoin, I don't think I would bear much in the way of transactions until we get maybe some changes on the tax front.”</p>\n<p><b>Why It Matters:</b>From a tax point of view, the IRS currently treats Bitcoin and other cryptocurrencies as “property,”&nbsp;as they do stocks and bonds. As a result, when investors sell their Bitcoin for fiat currency or use it as a means to purchase another good, they could be subject to massive capital gains taxes.</p>\n<p>Capital gains on taxes on assets that have been held for less than a year are taxed the same&nbsp;as a person’s “other income,”&nbsp;while assets that are held for longer than this period would be subject to long-term capital gains taxes ranging from 15-20%.</p>\n<p>While this would make any Tesla purchases with Bitcoin somewhat unfavorable for those that bought the cryptocurrency last year, more recent investors may actually benefit from the current rules.</p>\n<p>For instance, if an investor purchased the leading cryptocurrency&nbsp;at a higher price than its current value, he or she could actually report a loss and receive a tax deduction for the value of the asset.</p>\n<p><b>Price Action:</b>After a volatile week, Bitcoin price recovered from yesterday's low of&nbsp;$50,856&nbsp;to $53,900 today. At press time, the cryptocurrency was trading at $53,223, according to data from CoinMarketCap.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKG":"ARK Genomic Revolution ETF","ARKK":"ARK Innovation ETF","GBTC":"Grayscale Bitcoin Trust"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160686264","content_text":"Earlier this week,Tesla Inc(NASDAQ:TSLA) announced that customers could now buy Tesla with Bitcoin (CRYPTO: BTC), but Ark Invest's Cathie Wood isn’t so sure investors should use it as a means of payment.\nWhat Happened:In a webcast hosted by CBOE, Wood said that those that made profits from Bitcoin’s rally may be the subject of scrutiny by the IRS.\nThe ARK Invest founder explained, \"The IRS has something to say about this, so if you have huge gains in your bitcoin, I don't think I would bear much in the way of transactions until we get maybe some changes on the tax front.”\nWhy It Matters:From a tax point of view, the IRS currently treats Bitcoin and other cryptocurrencies as “property,” as they do stocks and bonds. As a result, when investors sell their Bitcoin for fiat currency or use it as a means to purchase another good, they could be subject to massive capital gains taxes.\nCapital gains on taxes on assets that have been held for less than a year are taxed the same as a person’s “other income,” while assets that are held for longer than this period would be subject to long-term capital gains taxes ranging from 15-20%.\nWhile this would make any Tesla purchases with Bitcoin somewhat unfavorable for those that bought the cryptocurrency last year, more recent investors may actually benefit from the current rules.\nFor instance, if an investor purchased the leading cryptocurrency at a higher price than its current value, he or she could actually report a loss and receive a tax deduction for the value of the asset.\nPrice Action:After a volatile week, Bitcoin price recovered from yesterday's low of $50,856 to $53,900 today. At press time, the cryptocurrency was trading at $53,223, according to data from CoinMarketCap.","news_type":1},"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":356192119,"gmtCreate":1616762337131,"gmtModify":1704798521187,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"No doubt the future potential is there.&nbsp;","listText":"No doubt the future potential is there.&nbsp;","text":"No doubt the future potential is there.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/356192119","repostId":"2122444907","repostType":4,"isVote":1,"tweetType":1,"viewCount":374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":356196086,"gmtCreate":1616762262545,"gmtModify":1704798520696,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"As long as it is fluctuating in a decent range, it mean good for trader.&nbsp;","listText":"As long as it is fluctuating in a decent range, it mean good for trader.&nbsp;","text":"As long as it is fluctuating in a decent range, it mean good for trader.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/356196086","repostId":"1141702651","repostType":4,"repost":{"id":"1141702651","pubTimestamp":1616751072,"share":"https://ttm.financial/m/news/1141702651?lang=&edition=fundamental","pubTime":"2021-03-26 17:31","market":"fut","language":"en","title":"Bitcoin's Never-Ending Bubble and Other Mysteries","url":"https://stock-news.laohu8.com/highlight/detail?id=1141702651","media":"Bloomberg","summary":"There’s no shortage of ethereal matters for reflection as we embark on a holy week.\nIt rises again, ","content":"<p>There’s no shortage of ethereal matters for reflection as we embark on a holy week.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ec58915d0f6d7c92a46d6d7130f728d9\" tg-width=\"2000\" tg-height=\"1225\"><span>It rises again, and again. Photographer: INA FASSBENDER/AFP/Getty Images</span></p>\n<p><b>Four Financial Questions for Passover</b></p>\n<p>It’s that time of year again. On Saturday night, the world’s Jews sit down for a “seder” meal, to commemorate the exodus from Egypt. Jesus’s Last Supper&nbsp;was a seder, so this is a rite of fundamental importance to two of the world’s great religions. Early in proceedings, the youngest person has to ask four questions, about why things are different on the nights of Passover compared to all other nights.</p>\n<p>For years now, I’ve tried to come up with four financial questions each Passover; questions that show contradictions in where financial markets have reached, and attempt to clarify the issues ahead of us. This year I’ve found it much harder than usual. This isn’t because it’s challenging&nbsp;to come up with questions, but because it’s difficult to edit them down to four. We exited financial crisis conditions about a year ago, but much about the world of money is genuinely unprecedented. It’s an overused word, but amply justified these days. Much of this can be attributed to our contemporary plague, a most unwelcome echo of the Passover story. But not all of it.</p>\n<p>Not only is it difficult to whittle down the questions; it’s harder than usual to answer them.&nbsp;I hope what follows will be a useful stimulus to thought as many of us embark on a holy week, with Passover followed by Palm Sunday.</p>\n<p><b>Why are stocks so incredibly high when they have scarcely ever been so expensive before, and our lives are still terribly affected by a pandemic?</b></p>\n<p>Yes, stocks are really, really high, in the U.S. By far the best known measure of long-term valuation is Robert Shiller’s cyclically adjusted price-earnings ratio. The latest reading is 35 times inflation-adjusted earnings for the last decade; higher than at any time since Shiller’s data begin&nbsp;in 1880, bar the dot-com bubble, which isn’t a reassuring precedent. This is the latest chart from his website:</p>\n<p><img src=\"https://static.tigerbbs.com/7c45cd91751a8ef11538128ddcd8ed25\" tg-width=\"534\" tg-height=\"368\"></p>\n<p>Shiller’s chart includes long-term interest rates, which have just started to rebound from a historic low. Naturally, such rock-bottom rates are the main reason why stocks have reached such extreme valuations. But Shiller’s excess CAPE yield, which tries to predict future relative performance by comparing stock earnings&nbsp;yields with those on bonds, isn’t that exciting. At 3%, this measure isn’t flashing any great signal to dive into stocks, although it certainly shows that buying now isn’t as dangerous as it would have been at the top of the bubble&nbsp;in 2000:</p>\n<p><img src=\"https://static.tigerbbs.com/a6a1b1660b6701c007b33e78c2f3d5c1\" tg-width=\"848\" tg-height=\"583\"></p>\n<p>The rebound from last year’s turmoil has come with indecent haste. As I showed earlier this week, this has been the best 12 months for the S&amp;P 500 ever, and it is a massive outlier. On the face of it, this rally screams “unsustainable”:</p>\n<p><img src=\"https://static.tigerbbs.com/8d52444ab8a756262ae3fd623880190f\" tg-width=\"544\" tg-height=\"516\"></p>\n<p>Earnings are recovering nicely, and there is quite an economic rebound in prospect (as I’ll cover later). And the pandemic has scrambled perceptions and much very real data. It would be no surprise if markets, and economies, are overshooting in both directions. But there is only so far this can be taken. Shiller’s data go back a long way. They cover plenty of economic booms and busts. Ultimately, stock markets at these levels can only be attributed to injections of liquidity on a massive scale. They were made to tide us through the pandemic shutdowns, but intriguingly they are continuing. This is the measure of global central bank liquidity injections kept by CrossBorder Capital Ltd. of London. They are at record levels, and haven’t yet started to reduce.</p>\n<p><img src=\"https://static.tigerbbs.com/21764913df0bdc7e009231d7f4fde500\" tg-width=\"1491\" tg-height=\"523\"></p>\n<p>While this remains the case, it’s hard for stocks to go down very much. It does rather raise the question of whether liquidity injections on such a scale can continue. That brings us to the next question:</p>\n<p><b>Why are bond yields still so incredibly low when everyone is bracing&nbsp;for the return of inflation, and at all other times that means higher yields?</b></p>\n<p>Yes, yields have come back a lot, but that’s only because they hit an historic low during a moment of existential panic in the early weeks of the Covid-19 crisis last year. That dip in yields looks like a true historical outlier. But if we look&nbsp;at the long-term trend for 10-year Treasury yields, which have been falling steadily ever since Paul Volcker worked his anti-inflationary magic in the early 1980s, they have room to rise further before they challenge the declining trend.</p>\n<p><img src=\"https://static.tigerbbs.com/8bbd61f3490015a830fa47dbc7b3f2f5\" tg-width=\"624\" tg-height=\"353\"></p>\n<p>This seems extraordinary in the light of the borrowing being conducted by governments to pay for their pandemic-fighting measures, which should all else equal lead to higher yields, and in the light of the widespread belief that inflation is set to take hold again. So why are bond yields still historically low?</p>\n<p>Earlier this week, I&nbsp;quoted&nbsp;my Bloomberg Opinion colleague Jim Bianco who said last March, as the Fed was rolling out its measures to bolster the market, that we had seen the virtual “nationalization” of the bond markets. He sent me this chart, to show that he had been right:</p>\n<p><img src=\"https://static.tigerbbs.com/27c30feaec47168ed62b8bf33f35692b\" tg-width=\"1658\" tg-height=\"1242\"></p>\n<p>Buying on such a scale can fairly be called nationalization. While yields have picked up of late, and there has been much excitement over how far the Fed would allow yields to rise, the basic Fedspeak is clear. Bond yields aren’t going to be allowed to rise to a point where they jeopardize the attempt to buy full employment, or to the point where they trigger a major selloff. With central banks so determined to keep the nationalized bond market under control, risks of suffering a big loss continue to be low, and people keep buying. But that leads to the next question:</p>\n<p><b>Why are central banks and governments still trying so hard to stimulate the economy, when we are told the recession is all over and victory over the pandemic is assured?</b></p>\n<p>This comes close to a Catch-22. If stocks are up because recovery is assured, then there is no need for further Fed assistance (or fiscal aid). And if we do have a recovery, then there is inflation ahead, which could mess up all our plans. Politicians and central bankers are plainly prepared to run the risk of inflation, and their gambit has divided economists. As&nbsp;this great round-up of their views by Neil Irwin in the New York Times&nbsp;shows, this is no longer the standard battle between left and right; economists who normally agree with each other, and normally back bigger spending, are growing very divided.</p>\n<p>Last year’s economic stimulus to combat the virus was indeed huge, as this chart from Marko Papic of the Clocktower Group makes clear:</p>\n<p><img src=\"https://static.tigerbbs.com/8a83a6ca65db5867ede7b565ccdfb0c5\" tg-width=\"447\" tg-height=\"265\"></p>\n<p>Adding fiscal stimulus makes this a measure unseen in peacetime. U.S. GDP growth is already at this point humming along at an annualized rate of 5.4%, according to the Atlanta Fed’s Nowcast. That can be expected to increase. And yet the Biden administration seems determined to pump more money into the economy, now to work on improving infrastructure.</p>\n<p>To some extent, the answer to why the U.S. government is doing this —&nbsp;and it has analogues elsewhere in the world —&nbsp;is reasonably clear. Populist movements demonstrate that support for such policies is growing. Inequality is deeper than ever. Appalling statistics on deaths of despair showed that something was wrong long before the pandemic. At this point, perhaps it is best to believe the Fed, and the politicians currently running the U.S., that they really do mean what they say. They’re making the judgment that unemployment has to be tamed, and inequality has to come down, whatever that means for inflation.</p>\n<p>There are fascinating parallels with Franklin Roosevelt, not initially a fan of&nbsp;big government spending, who took office and decided to embark on the New Deal. Now Biden is also, to continue the Passover analogy, attempting to lead us all to the Promised Land. Such a radical departure may or may not work; that whole issue raises many more than four questions. But if we’re clear that the government apparatus has decided to change the paradigm, spend in a way it hasn’t done before, and risk inflation of a kind that hasn’t been seen in a generation, a lot of other market judgments seem mutually inconsistent. If that’s our future, low bond yields are going away soon. And if they don’t, then inflation is coming back. A great economy, in which people want to buy things other than financial assets, isn’t great for stock markets. And if this concerted attempt fails, and we are left with a very heavy and deeply indebted government presiding over continued slow and inequitable growth, that doesn’t sound very appealing either.</p>\n<p><b>Why is bitcoin at an all-time high, and when we still have no idea whether governments will allow it to persist?</b></p>\n<p>Why even mention bitcoin? Because it is getting very big, and some of the easier assumptions about the cryptocurrency no longer look firm. The following chart, from Goldman Sachs Group Inc., compares bitcoin’s performance over the last 12 months to some of the biggest bubbles in history. Note that the S&amp;P 500 over the same period, on the same scale, looks horizontal, as does the Dow Industrials in the 12 months leading up to the Great Crash of 1929:</p>\n<p><img src=\"https://static.tigerbbs.com/a36d433abf200cc59593b22d164e9f45\" tg-width=\"1545\" tg-height=\"1211\"></p>\n<p>There we have it, it would seem. Bitcoin is a classic mania, that will need to go into the next edition of Charles Kindleberger's<i>Manias, Panics and Crashes</i>. A gain like that is ridiculous and completely unjustified, particularly for an asset whose underlying value is, if anything, even less well-rooted than that of a tulip bulb. I’ve had fun comparing bitcoin to Tulipmania myself, and the comparisons are obvious.</p>\n<p>There is a rub, though. I wrote a couple of essays pointing out the parallels between bitcoin&nbsp;and tulip bubbles back in late 2017. That was when bitcoin was also in the grip of a historic bubble. In terms of its percentage rise, that bubble was even bigger than this one. And indeed, looking at bitcoin’s price over the decade or so of its existence, on a log scale, we find that there have already been at least four other bubbles:</p>\n<p><img src=\"https://static.tigerbbs.com/7cd8abe2626645705bb2c23de23e0a79\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>When all the other great bubbles in history burst, they stayed burst. The point of labeling the phenomenon a “bubble” is that bubbles must inevitably pop; they cannot deflate gently and then re-inflate. There has never, ever been any asset that has staged a series of bubbles, crashed after each of them, and after a while&nbsp;regrouped to stage another bubble, the way bitcoin has. Usually, you expect to wait a generation for another serious bubble to come along, after people who were burned the first time have left the scene.</p>\n<p>We live in a world where central banks are growing ever more dominant actors in the economy. Governments maintain a monopoly over currency, and it is unlikely they will want to give it up. Bitcoin mining is a colossal waste of energy and computing power. But the bitcoin network is steadily spreading, and people are finding uses for it.</p>\n<p>I still have plenty of problems with bitcoin. Many of those interested come across as evangelizers. It’s never healthy to “believe” rather than “invest” in a financial asset. The narrative around bitcoin sounds a little too wonderful to be true. It’s always possible for others (including central banks) to introduce their own cryptocurrencies. But all bitcoin skeptics have to accept that something new and different is going on here. It has a market cap of about $600 billion. That’s&nbsp;only a third the size of Apple Inc., but it’s a lot of money.</p>\n<p>All other bubbles on the scale of bitcoin led to complete collapse within a year, never to return. Bitcoin’s bubble has burst four times, but never gone to zero, and then staged a comeback. How?</p>\n<p><b>Survival Tips</b></p>\n<p>Some music for the seder nights and Palm Sunday is in order. First, to hear the four questions sung a capella by local heroes the Maccabeats, listen tothis. Then to get in the mood for Easter, you can follow the events at the most dramatic seder ever held in the&nbsp;Last Supper scene from Jesus Christ Superstar.&nbsp;Judas explains why he decided to betray Jesus in&nbsp;Heaven on Their Minds, the opening song of the musical. And the whole story of Holy Week was told perfectly in&nbsp;Bach's St John Passion, as conducted by the great Nikolaus Harnoncourt.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin's Never-Ending Bubble and Other Mysteries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin's Never-Ending Bubble and Other Mysteries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-26 17:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://bloomberg.com/opinion/articles/2021-03-26/bitcoin-s-never-ending-bubble-and-other-mysteries-for-holy-week?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There’s no shortage of ethereal matters for reflection as we embark on a holy week.\nIt rises again, and again. Photographer: INA FASSBENDER/AFP/Getty Images\nFour Financial Questions for Passover\nIt’s ...</p>\n\n<a href=\"http://bloomberg.com/opinion/articles/2021-03-26/bitcoin-s-never-ending-bubble-and-other-mysteries-for-holy-week?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQ":"Block","PYPL":"PayPal","TSLA":"特斯拉","GBTC":"Grayscale Bitcoin Trust"},"source_url":"http://bloomberg.com/opinion/articles/2021-03-26/bitcoin-s-never-ending-bubble-and-other-mysteries-for-holy-week?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141702651","content_text":"There’s no shortage of ethereal matters for reflection as we embark on a holy week.\nIt rises again, and again. Photographer: INA FASSBENDER/AFP/Getty Images\nFour Financial Questions for Passover\nIt’s that time of year again. On Saturday night, the world’s Jews sit down for a “seder” meal, to commemorate the exodus from Egypt. Jesus’s Last Supper was a seder, so this is a rite of fundamental importance to two of the world’s great religions. Early in proceedings, the youngest person has to ask four questions, about why things are different on the nights of Passover compared to all other nights.\nFor years now, I’ve tried to come up with four financial questions each Passover; questions that show contradictions in where financial markets have reached, and attempt to clarify the issues ahead of us. This year I’ve found it much harder than usual. This isn’t because it’s challenging to come up with questions, but because it’s difficult to edit them down to four. We exited financial crisis conditions about a year ago, but much about the world of money is genuinely unprecedented. It’s an overused word, but amply justified these days. Much of this can be attributed to our contemporary plague, a most unwelcome echo of the Passover story. But not all of it.\nNot only is it difficult to whittle down the questions; it’s harder than usual to answer them. I hope what follows will be a useful stimulus to thought as many of us embark on a holy week, with Passover followed by Palm Sunday.\nWhy are stocks so incredibly high when they have scarcely ever been so expensive before, and our lives are still terribly affected by a pandemic?\nYes, stocks are really, really high, in the U.S. By far the best known measure of long-term valuation is Robert Shiller’s cyclically adjusted price-earnings ratio. The latest reading is 35 times inflation-adjusted earnings for the last decade; higher than at any time since Shiller’s data begin in 1880, bar the dot-com bubble, which isn’t a reassuring precedent. This is the latest chart from his website:\n\nShiller’s chart includes long-term interest rates, which have just started to rebound from a historic low. Naturally, such rock-bottom rates are the main reason why stocks have reached such extreme valuations. But Shiller’s excess CAPE yield, which tries to predict future relative performance by comparing stock earnings yields with those on bonds, isn’t that exciting. At 3%, this measure isn’t flashing any great signal to dive into stocks, although it certainly shows that buying now isn’t as dangerous as it would have been at the top of the bubble in 2000:\n\nThe rebound from last year’s turmoil has come with indecent haste. As I showed earlier this week, this has been the best 12 months for the S&P 500 ever, and it is a massive outlier. On the face of it, this rally screams “unsustainable”:\n\nEarnings are recovering nicely, and there is quite an economic rebound in prospect (as I’ll cover later). And the pandemic has scrambled perceptions and much very real data. It would be no surprise if markets, and economies, are overshooting in both directions. But there is only so far this can be taken. Shiller’s data go back a long way. They cover plenty of economic booms and busts. Ultimately, stock markets at these levels can only be attributed to injections of liquidity on a massive scale. They were made to tide us through the pandemic shutdowns, but intriguingly they are continuing. This is the measure of global central bank liquidity injections kept by CrossBorder Capital Ltd. of London. They are at record levels, and haven’t yet started to reduce.\n\nWhile this remains the case, it’s hard for stocks to go down very much. It does rather raise the question of whether liquidity injections on such a scale can continue. That brings us to the next question:\nWhy are bond yields still so incredibly low when everyone is bracing for the return of inflation, and at all other times that means higher yields?\nYes, yields have come back a lot, but that’s only because they hit an historic low during a moment of existential panic in the early weeks of the Covid-19 crisis last year. That dip in yields looks like a true historical outlier. But if we look at the long-term trend for 10-year Treasury yields, which have been falling steadily ever since Paul Volcker worked his anti-inflationary magic in the early 1980s, they have room to rise further before they challenge the declining trend.\n\nThis seems extraordinary in the light of the borrowing being conducted by governments to pay for their pandemic-fighting measures, which should all else equal lead to higher yields, and in the light of the widespread belief that inflation is set to take hold again. So why are bond yields still historically low?\nEarlier this week, I quoted my Bloomberg Opinion colleague Jim Bianco who said last March, as the Fed was rolling out its measures to bolster the market, that we had seen the virtual “nationalization” of the bond markets. He sent me this chart, to show that he had been right:\n\nBuying on such a scale can fairly be called nationalization. While yields have picked up of late, and there has been much excitement over how far the Fed would allow yields to rise, the basic Fedspeak is clear. Bond yields aren’t going to be allowed to rise to a point where they jeopardize the attempt to buy full employment, or to the point where they trigger a major selloff. With central banks so determined to keep the nationalized bond market under control, risks of suffering a big loss continue to be low, and people keep buying. But that leads to the next question:\nWhy are central banks and governments still trying so hard to stimulate the economy, when we are told the recession is all over and victory over the pandemic is assured?\nThis comes close to a Catch-22. If stocks are up because recovery is assured, then there is no need for further Fed assistance (or fiscal aid). And if we do have a recovery, then there is inflation ahead, which could mess up all our plans. Politicians and central bankers are plainly prepared to run the risk of inflation, and their gambit has divided economists. As this great round-up of their views by Neil Irwin in the New York Times shows, this is no longer the standard battle between left and right; economists who normally agree with each other, and normally back bigger spending, are growing very divided.\nLast year’s economic stimulus to combat the virus was indeed huge, as this chart from Marko Papic of the Clocktower Group makes clear:\n\nAdding fiscal stimulus makes this a measure unseen in peacetime. U.S. GDP growth is already at this point humming along at an annualized rate of 5.4%, according to the Atlanta Fed’s Nowcast. That can be expected to increase. And yet the Biden administration seems determined to pump more money into the economy, now to work on improving infrastructure.\nTo some extent, the answer to why the U.S. government is doing this — and it has analogues elsewhere in the world — is reasonably clear. Populist movements demonstrate that support for such policies is growing. Inequality is deeper than ever. Appalling statistics on deaths of despair showed that something was wrong long before the pandemic. At this point, perhaps it is best to believe the Fed, and the politicians currently running the U.S., that they really do mean what they say. They’re making the judgment that unemployment has to be tamed, and inequality has to come down, whatever that means for inflation.\nThere are fascinating parallels with Franklin Roosevelt, not initially a fan of big government spending, who took office and decided to embark on the New Deal. Now Biden is also, to continue the Passover analogy, attempting to lead us all to the Promised Land. Such a radical departure may or may not work; that whole issue raises many more than four questions. But if we’re clear that the government apparatus has decided to change the paradigm, spend in a way it hasn’t done before, and risk inflation of a kind that hasn’t been seen in a generation, a lot of other market judgments seem mutually inconsistent. If that’s our future, low bond yields are going away soon. And if they don’t, then inflation is coming back. A great economy, in which people want to buy things other than financial assets, isn’t great for stock markets. And if this concerted attempt fails, and we are left with a very heavy and deeply indebted government presiding over continued slow and inequitable growth, that doesn’t sound very appealing either.\nWhy is bitcoin at an all-time high, and when we still have no idea whether governments will allow it to persist?\nWhy even mention bitcoin? Because it is getting very big, and some of the easier assumptions about the cryptocurrency no longer look firm. The following chart, from Goldman Sachs Group Inc., compares bitcoin’s performance over the last 12 months to some of the biggest bubbles in history. Note that the S&P 500 over the same period, on the same scale, looks horizontal, as does the Dow Industrials in the 12 months leading up to the Great Crash of 1929:\n\nThere we have it, it would seem. Bitcoin is a classic mania, that will need to go into the next edition of Charles Kindleberger'sManias, Panics and Crashes. A gain like that is ridiculous and completely unjustified, particularly for an asset whose underlying value is, if anything, even less well-rooted than that of a tulip bulb. I’ve had fun comparing bitcoin to Tulipmania myself, and the comparisons are obvious.\nThere is a rub, though. I wrote a couple of essays pointing out the parallels between bitcoin and tulip bubbles back in late 2017. That was when bitcoin was also in the grip of a historic bubble. In terms of its percentage rise, that bubble was even bigger than this one. And indeed, looking at bitcoin’s price over the decade or so of its existence, on a log scale, we find that there have already been at least four other bubbles:\n\nWhen all the other great bubbles in history burst, they stayed burst. The point of labeling the phenomenon a “bubble” is that bubbles must inevitably pop; they cannot deflate gently and then re-inflate. There has never, ever been any asset that has staged a series of bubbles, crashed after each of them, and after a while regrouped to stage another bubble, the way bitcoin has. Usually, you expect to wait a generation for another serious bubble to come along, after people who were burned the first time have left the scene.\nWe live in a world where central banks are growing ever more dominant actors in the economy. Governments maintain a monopoly over currency, and it is unlikely they will want to give it up. Bitcoin mining is a colossal waste of energy and computing power. But the bitcoin network is steadily spreading, and people are finding uses for it.\nI still have plenty of problems with bitcoin. Many of those interested come across as evangelizers. It’s never healthy to “believe” rather than “invest” in a financial asset. The narrative around bitcoin sounds a little too wonderful to be true. It’s always possible for others (including central banks) to introduce their own cryptocurrencies. But all bitcoin skeptics have to accept that something new and different is going on here. It has a market cap of about $600 billion. That’s only a third the size of Apple Inc., but it’s a lot of money.\nAll other bubbles on the scale of bitcoin led to complete collapse within a year, never to return. Bitcoin’s bubble has burst four times, but never gone to zero, and then staged a comeback. How?\nSurvival Tips\nSome music for the seder nights and Palm Sunday is in order. First, to hear the four questions sung a capella by local heroes the Maccabeats, listen tothis. Then to get in the mood for Easter, you can follow the events at the most dramatic seder ever held in the Last Supper scene from Jesus Christ Superstar. Judas explains why he decided to betray Jesus in Heaven on Their Minds, the opening song of the musical. And the whole story of Holy Week was told perfectly in Bach's St John Passion, as conducted by the great Nikolaus Harnoncourt.","news_type":1},"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":356191609,"gmtCreate":1616762167401,"gmtModify":1704798517766,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Short term impact meaning a&nbsp;good entry point for this stock will be available.&nbsp;","listText":"Short term impact meaning a&nbsp;good entry point for this stock will be available.&nbsp;","text":"Short term impact meaning a good entry point for this stock will be available.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/356191609","repostId":"1147585149","repostType":4,"repost":{"id":"1147585149","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1616746548,"share":"https://ttm.financial/m/news/1147585149?lang=&edition=fundamental","pubTime":"2021-03-26 16:15","market":"us","language":"en","title":"NIO: It is estimated that approximately 19,500 vehicles will be delivered in the first quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=1147585149","media":"Tiger Newspress","summary":"* ANNOUNCES TEMPORARY SUSPENSION OF PRODUCTION FOR FIVE WORKING DAYS. * NIO TO TEMPORARILY SUSPEND VEHICLE PRODUCTION ACTIVITY IN JAC-NIO MANUFACTURING PLANT IN HEFEI. * NIO - EXPECTS TO DELIVER APPROXIMATELY 19,500 VEHICLES IN Q1 OF 2021, ADJUSTED FROM PREVIOUSLY RELEASED OUTLOOK OF 20,000 TO 20,500 VEHICLES. * SUSPENSION FOR FIVE WORKING DAYS STARTING FROM MARCH 29, 2021 DUE TO SEMICONDUCTOR SHORTAGE. * OVERALL SUPPLY CONSTRAINT OF SEMICONDUCTORS HAS IMPACTED COMPANY'S PRODUCTION VOLUME IN MAR","content":"<p>March 26 - NIO Inc :</p><p>* ANNOUNCES TEMPORARY SUSPENSION OF PRODUCTION FOR FIVE WORKING DAYS</p><p>* NIO TO TEMPORARILY SUSPEND VEHICLE PRODUCTION ACTIVITY IN JAC-NIO MANUFACTURING PLANT IN HEFEI</p><p>* NIO - EXPECTS TO DELIVER APPROXIMATELY 19,500 VEHICLES IN Q1 OF 2021, ADJUSTED FROM PREVIOUSLY RELEASED OUTLOOK OF 20,000 TO 20,500 VEHICLES</p><p>* SUSPENSION FOR FIVE WORKING DAYS STARTING FROM MARCH 29, 2021 DUE TO SEMICONDUCTOR SHORTAGE</p><p>* OVERALL SUPPLY CONSTRAINT OF SEMICONDUCTORS HAS IMPACTED COMPANY'S PRODUCTION VOLUME IN MARCH 2021</p><p>NIO the gain narrowed to 2%&nbsp;in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/d37d09d58fb11d69c2992ca348dbc68b\" tg-width=\"852\" tg-height=\"661\" referrerpolicy=\"no-referrer\"></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO: It is estimated that approximately 19,500 vehicles will be delivered in the first quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO: It is estimated that approximately 19,500 vehicles will be delivered in the first quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-26 16:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>March 26 - NIO Inc :</p><p>* ANNOUNCES TEMPORARY SUSPENSION OF PRODUCTION FOR FIVE WORKING DAYS</p><p>* NIO TO TEMPORARILY SUSPEND VEHICLE PRODUCTION ACTIVITY IN JAC-NIO MANUFACTURING PLANT IN HEFEI</p><p>* NIO - EXPECTS TO DELIVER APPROXIMATELY 19,500 VEHICLES IN Q1 OF 2021, ADJUSTED FROM PREVIOUSLY RELEASED OUTLOOK OF 20,000 TO 20,500 VEHICLES</p><p>* SUSPENSION FOR FIVE WORKING DAYS STARTING FROM MARCH 29, 2021 DUE TO SEMICONDUCTOR SHORTAGE</p><p>* OVERALL SUPPLY CONSTRAINT OF SEMICONDUCTORS HAS IMPACTED COMPANY'S PRODUCTION VOLUME IN MARCH 2021</p><p>NIO the gain narrowed to 2%&nbsp;in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/d37d09d58fb11d69c2992ca348dbc68b\" tg-width=\"852\" tg-height=\"661\" referrerpolicy=\"no-referrer\"></p><p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/a3b92523152bd36c422721756606e549","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147585149","content_text":"March 26 - NIO Inc :* ANNOUNCES TEMPORARY SUSPENSION OF PRODUCTION FOR FIVE WORKING DAYS* NIO TO TEMPORARILY SUSPEND VEHICLE PRODUCTION ACTIVITY IN JAC-NIO MANUFACTURING PLANT IN HEFEI* NIO - EXPECTS TO DELIVER APPROXIMATELY 19,500 VEHICLES IN Q1 OF 2021, ADJUSTED FROM PREVIOUSLY RELEASED OUTLOOK OF 20,000 TO 20,500 VEHICLES* SUSPENSION FOR FIVE WORKING DAYS STARTING FROM MARCH 29, 2021 DUE TO SEMICONDUCTOR SHORTAGE* OVERALL SUPPLY CONSTRAINT OF SEMICONDUCTORS HAS IMPACTED COMPANY'S PRODUCTION VOLUME IN MARCH 2021NIO the gain narrowed to 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":350307379,"gmtCreate":1616157471391,"gmtModify":1704791645483,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Great news.&nbsp;","listText":"Great news.&nbsp;","text":"Great news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350307379","repostId":"2120118242","repostType":2,"repost":{"id":"2120118242","pubTimestamp":1616155200,"share":"https://ttm.financial/m/news/2120118242?lang=&edition=fundamental","pubTime":"2021-03-19 20:00","market":"us","language":"en","title":"Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation","url":"https://stock-news.laohu8.com/highlight/detail?id=2120118242","media":"Business Wire","summary":"Data from the randomized, Phase 3 ARIEL4 study to be presented today at the Society of Gynecologic O","content":"<html><body><ul>\n<li>Data from the randomized, Phase 3 ARIEL4 study to be presented today at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer</li>\n<li>The ARIEL4 study met its primary endpoint, showing a statistically significant improvement in investigator-assessed progression-free survival (PFS) for Rubraca versus chemotherapy</li>\n<li>The safety of Rubraca observed in the ARIEL4 study was highly consistent with both the U.S. and EU product labels</li>\n</ul>\n<p><a href=\"https://laohu8.com/S/CLVS\">Clovis Oncology</a>, Inc. (NASDAQ: CLVS) announced that the first presentation of data from the randomized, Phase 3 ARIEL4 study of Rubraca<b>®</b> (rucaparib) will take place today in an oral presentation at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer (SGO). The data demonstrate that Rubraca significantly improves PFS compared to standard-of-care chemotherapy, including platinum-based chemotherapy, among patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation who have received two or more prior lines of chemotherapy.</p>\n<p>\"Data from the ARIEL4 study meaningfully enhance our understanding about the role of Rubraca among women with BRCA mutation-positive relapsed ovarian cancer, as well as the clinical relevance of BRCA reversion mutations,\" said Dr. Rebecca Kristeleit, Co-Coordinating Investigator of ARIEL4 and Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust, London, UK. \"This is important because women with more advanced disease have fewer treatment options, and it is increasingly important to understand how specific mutations affect treatment outcomes.\"</p>\n<p>Dr. Kristeleit will present \"Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase 3 study\" today during the SGO Scientific Plenary I: Innovation and Progress in Gynecologic Oncology session from 2:35 pm - 3:45 pm CT. The presentation can also be viewed at https://www.clovisoncology.com/pipeline/scientific-presentations/ starting today at 2:35 pm CT.</p>\n<p>The ARIEL4 study (NCT02855944) is a Phase 3 multicenter, randomized study evaluating Rubraca versus chemotherapy in fully platinum-sensitive, partially platinum-sensitive and platinum-resistant patients with relapsed ovarian cancer and a BRCA mutation (inclusive of germline and/or somatic) who have received two or more prior lines of chemotherapy. The primary endpoint of the study is investigator-assessed PFS, with a step-down analysis from the primary efficacy population (if significant) to the intent-to-treat (ITT) population.</p>\n<p>The study enrolled 349 women in Europe, Israel and North and South America. The primary efficacy population (n=325) comprised the group of patients with a deleterious tumor BRCA mutation and excluded those with a BRCA reversion mutation as determined by a blood test. The rucaparib arm in this population (n=220) achieved statistical significance over the chemotherapy arm (n=105) for the primary endpoint of PFS with a hazard ratio of 0.64 (p=0.001). The median PFS for the patients in the efficacy population treated with rucaparib was 7.4 months versus 5.7 months among those who received chemotherapy.</p>\n<p>Additionally, in the ITT population (n=349), the rucaparib arm (n=233) achieved statistical significance over the chemotherapy arm (n=116) for the primary endpoint of PFS with a hazard ratio of 0.67 (p=0.002). The median PFS for the patients in the ITT population treated with rucaparib was 7.4 months versus 5.7 months among those who received chemotherapy.</p>\n<p>Adverse events were consistent with the known safety profiles of Rubraca and chemotherapy. The most common (&gt;5%) treatment-emergent ≥grade 3 adverse events (TEAEs) among all patients treated with rucaparib (n=232) in the ARIEL4 study were anemia/decreased hemoglobin (22%), neutropenia/decreased absolute neutrophil count (10%), asthenia/fatigue (8%), thrombocytopenia/decreased platelets (8%), and increased ALT/AST (8%).</p>\n<p>\"The ARIEL4 data add to the growing scientific understanding about the clinical utilization of Rubraca compared to chemotherapy, including platinum-based chemotherapy, for women diagnosed with BRCA mutation-positive advanced ovarian cancer,\" said Patrick J. Mahaffy, President and CEO of Clovis Oncology. \"We remain committed to expanding treatment options for patients living with cancer and are pleased to share these data with physicians and their patients to help improve outcomes for women with ovarian cancer.\"</p>\n<p>According to the American Cancer Society, an estimated more than 21,000 women will be diagnosed with ovarian cancer in the United States and there will be an estimated nearly 14,000 deaths from ovarian cancer in 2021, and according to GLOBOCAN in 2020, an estimated 66,000 women in Europe are diagnosed each year with ovarian cancer, and ovarian cancer is among those cancers with the highest rate of deaths. According to the American Cancer Society, more than 75% of women are diagnosed with ovarian cancer at an advanced stage, and patients who are diagnosed with advanced ovarian cancer have a 70-95% chance of recurrence according to the Ovarian Cancer Research Alliance.</p>\n<p><b>About Rubraca (rucaparib)</b></p>\n<p>Rucaparib is an oral, small molecule inhibitor of PARP1, PARP2 and PARP3 being developed in multiple tumor types, including ovarian and metastatic castration-resistant prostate cancers, as monotherapy, and in combination with other anti-cancer agents. Exploratory studies in other tumor types are also underway.</p>\n<p><b>Rubraca Ovarian Cancer U.S. FDA Approved Indications</b></p>\n<p>Rubraca is indicated for the maintenance treatment of adult women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.</p>\n<p>Rubraca is indicated for the treatment of adult women with a deleterious BRCA mutation (germline and/or somatic)-associated epithelial ovarian, fallopian tube, or primary peritoneal cancer who have been treated with two or more chemotherapies. Select patients for therapy based on an FDA-approved companion diagnostic for Rubraca.</p>\n<p><b>Select Important Safety Information</b></p>\n<p>Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) have occurred in patients treated with Rubraca, and are potentially fatal adverse reactions. In 1146 treated patients, MDS/AML occurred in 20 patients (1.7%), including those in long term follow-up. Of these, 8 occurred during treatment or during the 28 day safety follow-up (0.7%). The duration of Rubraca treatment prior to the diagnosis of MDS/AML ranged from 1 month to approximately 53 months. The cases were typical of secondary MDS/cancer therapy-related AML; in all cases, patients had received previous platinum-containing regimens and/or other DNA damaging agents.</p>\n<p>Do not start Rubraca until patients have recovered from hematological toxicity caused by previous chemotherapy (≤ Grade 1). Monitor complete blood counts for cytopenia at baseline and monthly thereafter for clinically significant changes during treatment. For prolonged hematological toxicities (&gt; 4 weeks), interrupt Rubraca or reduce dose and monitor blood counts weekly until recovery. If the levels have not recovered to Grade 1 or less after 4 weeks or if MDS/AML is suspected, refer the patient to a hematologist for further investigations, including bone marrow analysis and blood sample for cytogenetics. If MDS/AML is confirmed, discontinue Rubraca.</p>\n<p>Based on its mechanism of action and findings from animal studies, Rubraca can cause fetal harm when administered to a pregnant woman. Apprise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment and for 6 months following the last dose of Rubraca.</p>\n<p>Most common adverse reactions in ARIEL3 (≥ 20%; Grade 1-4) were nausea (76%), fatigue/asthenia (73%), abdominal pain/distention (46%), rash (43%), dysgeusia (40%), anemia (39%), AST/ALT elevation (38%), constipation (37%), vomiting (37%), diarrhea (32%), thrombocytopenia (29%), nasopharyngitis/upper respiratory tract infection (29%), stomatitis (28%), decreased appetite (23%), and neutropenia (20%).</p>\n<p>Most common adverse reactions in Study 10 and ARIEL2 (≥ 20%; Grade 1-4) were nausea (77%), asthenia/fatigue (77%), vomiting (46%), anemia (44%), constipation (40%), dysgeusia (39%), decreased appetite (39%), diarrhea (34%), abdominal pain (32%), dyspnea (21%), and thrombocytopenia (21%).</p>\n<p>Co-administration of rucaparib can increase the systemic exposure of CYP1A2, CYP3A, CYP2C9, or CYP2C19 substrates, which may increase the risk of toxicities of these drugs. Adjust dosage of CYP1A2, CYP3A, CYP2C9, or CYP2C19 substrates, if clinically indicated. If co-administration with warfarin (a CYP2C9 substrate) cannot be avoided, consider increasing frequency of international normalized ratio (INR) monitoring.</p>\n<p>Because of the potential for serious adverse reactions in breast-fed children from Rubraca, advise lactating women not to breastfeed during treatment with Rubraca and for 2 weeks after the last dose.</p>\n<p>Click here or full Prescribing Information and additional Important Safety Information.</p>\n<p><b>Rubraca (rucaparib) European Union (EU) authorized use and Important Safety Information</b></p>\n<p>Rubraca is indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy.</p>\n<p>Rubraca is indicated as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with ≥2 prior lines of platinum-based chemotherapy, and who are unable to tolerate further platinum-based chemotherapy.</p>\n<p>Efficacy of Rubraca as treatment for relapsed or progressive epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) has not been investigated in patients who have received prior treatment with a PARP inhibitor. Therefore, use in this patient population is not recommended.</p>\n<p>Summary warnings and precautions:</p>\n<p>Hematological toxicity</p>\n<p>During treatment with Rubraca, events of myelosuppression (anemia, neutropenia, thrombocytopenia) may be observed and are typically first observed after 8–10 weeks of treatment with Rubraca. These reactions are manageable with routine medical treatment and/or dose adjustment for more severe cases. Complete blood count testing prior to starting treatment with Rubraca, and monthly thereafter, is advised. Patients should not start Rubraca treatment until they have recovered from hematological toxicities caused by previous chemotherapy (CTCAE grade ≥1).</p>\n<p>Supportive care and institutional guidelines should be implemented for the management of low blood counts for the treatment of anemia and neutropenia. Rubraca should be interrupted or dose reduced according to Table 1 (see Posology and Method of Administration [4.2] of the Summary of Product Characteristics [SPC]) and blood counts monitored weekly until recovery. If the levels have not recovered to CTCAE grade 1 or better after 4 weeks, the patient should be referred to a hematologist for further investigations.</p>\n<p>MDS/AML</p>\n<p>MDS/AML, including cases with fatal outcome, have been reported in patients who received Rubraca. The duration of therapy with Rubraca in patients who developed MDS/AML varied from less than 1 month to approximately 28 months.</p>\n<p>If MDS/AML is suspected, the patient should be referred to a hematologist for further investigations, including bone marrow analysis and blood sampling for cytogenetics. If, following investigation for prolonged hematological toxicity, MDS/AML is confirmed, Rubraca should be discontinued.</p>\n<p>Photosensitivity</p>\n<p>Photosensitivity has been observed in patients treated with Rubraca. Patients should avoid spending time in direct sunlight because they may burn more easily during Rubraca treatment; when outdoors, patients should wear a hat and protective clothing, and use sunscreen and lip balm with sun protection factor of 50 or greater.</p>\n<p>Gastrointestinal toxicities</p>\n<p>Gastrointestinal toxicities (nausea and vomiting) are frequently reported with Rubraca, and are generally low grade (CTCAE grade 1 or 2), and may be managed with dose reduction (refer to Posology and Method of Administration [4.2], Table 1 of the SPC) or interruption. Antiemetics, such as 5-HT3 antagonists, dexamethasone, aprepitant and fosaprepitant, can be used as treatment for nausea/vomiting and may also be considered for prophylactic (i.e. preventative) use prior to starting Rubraca. It is important to proactively manage these events to avoid prolonged or more severe events of nausea/vomiting which have the potential to lead to complications such as dehydration or hospitalization.</p>\n<p>Embryofetal toxicity</p>\n<p>Rubraca can cause fetal harm when administered to a pregnant woman based on its mechanism of action and findings from animal studies. In an animal reproduction study, administration of Rubraca to pregnant rats during the period of organogenesis resulted in embryo-fetal toxicity at exposures below those in patients receiving the recommended human dose of 600 mg twice daily (see Preclinical Safety Data [5.3] of the SPC).</p>\n<p>Pregnancy/contraception</p>\n<p>Pregnant women should be informed of the potential risk to a fetus. Women of reproductive potential should be advised to use effective contraception during treatment and for 6 months following the last dose of Rubraca (see section 4.6 of the SPC). A pregnancy test before initiating treatment is recommended in women of reproductive potential.</p>\n<p>Click here to access the current SPC. Healthcare professionals should report any suspected adverse reactions via their national reporting systems.</p>\n<p><b>About Clovis Oncology</b></p>\n<p>Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe. Please visit www.clovisoncology.com for more information.</p>\n<p><i>To the extent that statements contained in this press release are not descriptions of historical facts regarding Clovis Oncology, they are forward-looking statements reflecting the current beliefs and expectations of management. Examples of forward-looking statements contained in this press release include, among others, statements regarding the potential results of such clinical trials, our expectations regarding the suitability of Rubraca for certain patient populations or indications, and our plans to develop Rubraca in additional indications and tumor types, and our expectations regarding the outcomes of early studies or trials supporting further development, both non-clinical and clinical. Such forward-looking statements involve substantial risks and uncertainties that could cause our future results, performance or achievements to differ significantly from that expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in our clinical development programs for our drug candidates and those of our partners, whether future study results will be consistent with study findings to date, the timing of availability of data from our clinical trials and the initiation, enrollment, timing and results of our planned clinical trials and the corresponding development pathways, effectiveness and suitability of diagnostic tests, the risk that final results of ongoing trials may differ from initial or interim results as a result of factors such as final results from a larger patient population may be different from initial or interim results from a smaller patient population, the risk that additional pre-clinical or clinical studies may not support further development in certain additional indications or tumor types, and actions by the FDA, the EMA or other regulatory authorities regarding data required to support drug applications and whether to approve drug applications. Clovis Oncology does not undertake to update or revise any forward-looking statements. A further description of risks and uncertainties can be found in Clovis Oncology’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its reports on Form 10-Q and Form 8-K. </i></p>\n<p><span>View source version on businesswire.com: </span><span>https://www.businesswire.com/news/home/20210319005072/en/</span></p>\n<p><b>Contacts</b></p>\n<p><b>Clovis Investor Contacts: </b><br/>Anna Sussman, 303.625.5022 asussman@clovisoncology.com <br/>or<br/>Breanna Burkart, 303.625.5023 bburkart@clovisoncology.com</p>\n<p><b>Clovis Media Contacts:<br/>U.S. </b><br/>Lisa Guiterman, 301.217.9353 clovismedia@sambrown.com</p>\n<p><b>Europe </b><br/>Jake Davis, +44 (0) 20.3946.3538<br/>Jake.Davis@publicisresolute.com</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClovis Oncology’s Rubraca® (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-19 20:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/clovis-oncology-rubraca-rucaparib-significantly-120000293.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Data from the randomized, Phase 3 ARIEL4 study to be presented today at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer\nThe ARIEL4 study met its primary endpoint, showing ...</p>\n\n<a href=\"https://finance.yahoo.com/news/clovis-oncology-rubraca-rucaparib-significantly-120000293.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZmMq_SZJtNxTMvYN20q2ZA--~B/aD0xMDc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/rm0DJm9shwdmXqehYZ8SxA--~B/aD0xMDc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/05a3aae53790dee9f337fe6a7938a2c1","relate_stocks":{"CLVS":"Clovis Oncology"},"source_url":"https://finance.yahoo.com/news/clovis-oncology-rubraca-rucaparib-significantly-120000293.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2120118242","content_text":"Data from the randomized, Phase 3 ARIEL4 study to be presented today at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer\nThe ARIEL4 study met its primary endpoint, showing a statistically significant improvement in investigator-assessed progression-free survival (PFS) for Rubraca versus chemotherapy\nThe safety of Rubraca observed in the ARIEL4 study was highly consistent with both the U.S. and EU product labels\n\nClovis Oncology, Inc. (NASDAQ: CLVS) announced that the first presentation of data from the randomized, Phase 3 ARIEL4 study of Rubraca® (rucaparib) will take place today in an oral presentation at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer (SGO). The data demonstrate that Rubraca significantly improves PFS compared to standard-of-care chemotherapy, including platinum-based chemotherapy, among patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation who have received two or more prior lines of chemotherapy.\n\"Data from the ARIEL4 study meaningfully enhance our understanding about the role of Rubraca among women with BRCA mutation-positive relapsed ovarian cancer, as well as the clinical relevance of BRCA reversion mutations,\" said Dr. Rebecca Kristeleit, Co-Coordinating Investigator of ARIEL4 and Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust, London, UK. \"This is important because women with more advanced disease have fewer treatment options, and it is increasingly important to understand how specific mutations affect treatment outcomes.\"\nDr. Kristeleit will present \"Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase 3 study\" today during the SGO Scientific Plenary I: Innovation and Progress in Gynecologic Oncology session from 2:35 pm - 3:45 pm CT. The presentation can also be viewed at https://www.clovisoncology.com/pipeline/scientific-presentations/ starting today at 2:35 pm CT.\nThe ARIEL4 study (NCT02855944) is a Phase 3 multicenter, randomized study evaluating Rubraca versus chemotherapy in fully platinum-sensitive, partially platinum-sensitive and platinum-resistant patients with relapsed ovarian cancer and a BRCA mutation (inclusive of germline and/or somatic) who have received two or more prior lines of chemotherapy. The primary endpoint of the study is investigator-assessed PFS, with a step-down analysis from the primary efficacy population (if significant) to the intent-to-treat (ITT) population.\nThe study enrolled 349 women in Europe, Israel and North and South America. The primary efficacy population (n=325) comprised the group of patients with a deleterious tumor BRCA mutation and excluded those with a BRCA reversion mutation as determined by a blood test. The rucaparib arm in this population (n=220) achieved statistical significance over the chemotherapy arm (n=105) for the primary endpoint of PFS with a hazard ratio of 0.64 (p=0.001). The median PFS for the patients in the efficacy population treated with rucaparib was 7.4 months versus 5.7 months among those who received chemotherapy.\nAdditionally, in the ITT population (n=349), the rucaparib arm (n=233) achieved statistical significance over the chemotherapy arm (n=116) for the primary endpoint of PFS with a hazard ratio of 0.67 (p=0.002). The median PFS for the patients in the ITT population treated with rucaparib was 7.4 months versus 5.7 months among those who received chemotherapy.\nAdverse events were consistent with the known safety profiles of Rubraca and chemotherapy. The most common (>5%) treatment-emergent ≥grade 3 adverse events (TEAEs) among all patients treated with rucaparib (n=232) in the ARIEL4 study were anemia/decreased hemoglobin (22%), neutropenia/decreased absolute neutrophil count (10%), asthenia/fatigue (8%), thrombocytopenia/decreased platelets (8%), and increased ALT/AST (8%).\n\"The ARIEL4 data add to the growing scientific understanding about the clinical utilization of Rubraca compared to chemotherapy, including platinum-based chemotherapy, for women diagnosed with BRCA mutation-positive advanced ovarian cancer,\" said Patrick J. Mahaffy, President and CEO of Clovis Oncology. \"We remain committed to expanding treatment options for patients living with cancer and are pleased to share these data with physicians and their patients to help improve outcomes for women with ovarian cancer.\"\nAccording to the American Cancer Society, an estimated more than 21,000 women will be diagnosed with ovarian cancer in the United States and there will be an estimated nearly 14,000 deaths from ovarian cancer in 2021, and according to GLOBOCAN in 2020, an estimated 66,000 women in Europe are diagnosed each year with ovarian cancer, and ovarian cancer is among those cancers with the highest rate of deaths. According to the American Cancer Society, more than 75% of women are diagnosed with ovarian cancer at an advanced stage, and patients who are diagnosed with advanced ovarian cancer have a 70-95% chance of recurrence according to the Ovarian Cancer Research Alliance.\nAbout Rubraca (rucaparib)\nRucaparib is an oral, small molecule inhibitor of PARP1, PARP2 and PARP3 being developed in multiple tumor types, including ovarian and metastatic castration-resistant prostate cancers, as monotherapy, and in combination with other anti-cancer agents. Exploratory studies in other tumor types are also underway.\nRubraca Ovarian Cancer U.S. FDA Approved Indications\nRubraca is indicated for the maintenance treatment of adult women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.\nRubraca is indicated for the treatment of adult women with a deleterious BRCA mutation (germline and/or somatic)-associated epithelial ovarian, fallopian tube, or primary peritoneal cancer who have been treated with two or more chemotherapies. Select patients for therapy based on an FDA-approved companion diagnostic for Rubraca.\nSelect Important Safety Information\nMyelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) have occurred in patients treated with Rubraca, and are potentially fatal adverse reactions. In 1146 treated patients, MDS/AML occurred in 20 patients (1.7%), including those in long term follow-up. Of these, 8 occurred during treatment or during the 28 day safety follow-up (0.7%). The duration of Rubraca treatment prior to the diagnosis of MDS/AML ranged from 1 month to approximately 53 months. The cases were typical of secondary MDS/cancer therapy-related AML; in all cases, patients had received previous platinum-containing regimens and/or other DNA damaging agents.\nDo not start Rubraca until patients have recovered from hematological toxicity caused by previous chemotherapy (≤ Grade 1). Monitor complete blood counts for cytopenia at baseline and monthly thereafter for clinically significant changes during treatment. For prolonged hematological toxicities (> 4 weeks), interrupt Rubraca or reduce dose and monitor blood counts weekly until recovery. If the levels have not recovered to Grade 1 or less after 4 weeks or if MDS/AML is suspected, refer the patient to a hematologist for further investigations, including bone marrow analysis and blood sample for cytogenetics. If MDS/AML is confirmed, discontinue Rubraca.\nBased on its mechanism of action and findings from animal studies, Rubraca can cause fetal harm when administered to a pregnant woman. Apprise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment and for 6 months following the last dose of Rubraca.\nMost common adverse reactions in ARIEL3 (≥ 20%; Grade 1-4) were nausea (76%), fatigue/asthenia (73%), abdominal pain/distention (46%), rash (43%), dysgeusia (40%), anemia (39%), AST/ALT elevation (38%), constipation (37%), vomiting (37%), diarrhea (32%), thrombocytopenia (29%), nasopharyngitis/upper respiratory tract infection (29%), stomatitis (28%), decreased appetite (23%), and neutropenia (20%).\nMost common adverse reactions in Study 10 and ARIEL2 (≥ 20%; Grade 1-4) were nausea (77%), asthenia/fatigue (77%), vomiting (46%), anemia (44%), constipation (40%), dysgeusia (39%), decreased appetite (39%), diarrhea (34%), abdominal pain (32%), dyspnea (21%), and thrombocytopenia (21%).\nCo-administration of rucaparib can increase the systemic exposure of CYP1A2, CYP3A, CYP2C9, or CYP2C19 substrates, which may increase the risk of toxicities of these drugs. Adjust dosage of CYP1A2, CYP3A, CYP2C9, or CYP2C19 substrates, if clinically indicated. If co-administration with warfarin (a CYP2C9 substrate) cannot be avoided, consider increasing frequency of international normalized ratio (INR) monitoring.\nBecause of the potential for serious adverse reactions in breast-fed children from Rubraca, advise lactating women not to breastfeed during treatment with Rubraca and for 2 weeks after the last dose.\nClick here or full Prescribing Information and additional Important Safety Information.\nRubraca (rucaparib) European Union (EU) authorized use and Important Safety Information\nRubraca is indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy.\nRubraca is indicated as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with ≥2 prior lines of platinum-based chemotherapy, and who are unable to tolerate further platinum-based chemotherapy.\nEfficacy of Rubraca as treatment for relapsed or progressive epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) has not been investigated in patients who have received prior treatment with a PARP inhibitor. Therefore, use in this patient population is not recommended.\nSummary warnings and precautions:\nHematological toxicity\nDuring treatment with Rubraca, events of myelosuppression (anemia, neutropenia, thrombocytopenia) may be observed and are typically first observed after 8–10 weeks of treatment with Rubraca. These reactions are manageable with routine medical treatment and/or dose adjustment for more severe cases. Complete blood count testing prior to starting treatment with Rubraca, and monthly thereafter, is advised. Patients should not start Rubraca treatment until they have recovered from hematological toxicities caused by previous chemotherapy (CTCAE grade ≥1).\nSupportive care and institutional guidelines should be implemented for the management of low blood counts for the treatment of anemia and neutropenia. Rubraca should be interrupted or dose reduced according to Table 1 (see Posology and Method of Administration [4.2] of the Summary of Product Characteristics [SPC]) and blood counts monitored weekly until recovery. If the levels have not recovered to CTCAE grade 1 or better after 4 weeks, the patient should be referred to a hematologist for further investigations.\nMDS/AML\nMDS/AML, including cases with fatal outcome, have been reported in patients who received Rubraca. The duration of therapy with Rubraca in patients who developed MDS/AML varied from less than 1 month to approximately 28 months.\nIf MDS/AML is suspected, the patient should be referred to a hematologist for further investigations, including bone marrow analysis and blood sampling for cytogenetics. If, following investigation for prolonged hematological toxicity, MDS/AML is confirmed, Rubraca should be discontinued.\nPhotosensitivity\nPhotosensitivity has been observed in patients treated with Rubraca. Patients should avoid spending time in direct sunlight because they may burn more easily during Rubraca treatment; when outdoors, patients should wear a hat and protective clothing, and use sunscreen and lip balm with sun protection factor of 50 or greater.\nGastrointestinal toxicities\nGastrointestinal toxicities (nausea and vomiting) are frequently reported with Rubraca, and are generally low grade (CTCAE grade 1 or 2), and may be managed with dose reduction (refer to Posology and Method of Administration [4.2], Table 1 of the SPC) or interruption. Antiemetics, such as 5-HT3 antagonists, dexamethasone, aprepitant and fosaprepitant, can be used as treatment for nausea/vomiting and may also be considered for prophylactic (i.e. preventative) use prior to starting Rubraca. It is important to proactively manage these events to avoid prolonged or more severe events of nausea/vomiting which have the potential to lead to complications such as dehydration or hospitalization.\nEmbryofetal toxicity\nRubraca can cause fetal harm when administered to a pregnant woman based on its mechanism of action and findings from animal studies. In an animal reproduction study, administration of Rubraca to pregnant rats during the period of organogenesis resulted in embryo-fetal toxicity at exposures below those in patients receiving the recommended human dose of 600 mg twice daily (see Preclinical Safety Data [5.3] of the SPC).\nPregnancy/contraception\nPregnant women should be informed of the potential risk to a fetus. Women of reproductive potential should be advised to use effective contraception during treatment and for 6 months following the last dose of Rubraca (see section 4.6 of the SPC). A pregnancy test before initiating treatment is recommended in women of reproductive potential.\nClick here to access the current SPC. Healthcare professionals should report any suspected adverse reactions via their national reporting systems.\nAbout Clovis Oncology\nClovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe. Please visit www.clovisoncology.com for more information.\nTo the extent that statements contained in this press release are not descriptions of historical facts regarding Clovis Oncology, they are forward-looking statements reflecting the current beliefs and expectations of management. Examples of forward-looking statements contained in this press release include, among others, statements regarding the potential results of such clinical trials, our expectations regarding the suitability of Rubraca for certain patient populations or indications, and our plans to develop Rubraca in additional indications and tumor types, and our expectations regarding the outcomes of early studies or trials supporting further development, both non-clinical and clinical. Such forward-looking statements involve substantial risks and uncertainties that could cause our future results, performance or achievements to differ significantly from that expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in our clinical development programs for our drug candidates and those of our partners, whether future study results will be consistent with study findings to date, the timing of availability of data from our clinical trials and the initiation, enrollment, timing and results of our planned clinical trials and the corresponding development pathways, effectiveness and suitability of diagnostic tests, the risk that final results of ongoing trials may differ from initial or interim results as a result of factors such as final results from a larger patient population may be different from initial or interim results from a smaller patient population, the risk that additional pre-clinical or clinical studies may not support further development in certain additional indications or tumor types, and actions by the FDA, the EMA or other regulatory authorities regarding data required to support drug applications and whether to approve drug applications. Clovis Oncology does not undertake to update or revise any forward-looking statements. A further description of risks and uncertainties can be found in Clovis Oncology’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its reports on Form 10-Q and Form 8-K. \nView source version on businesswire.com: https://www.businesswire.com/news/home/20210319005072/en/\nContacts\nClovis Investor Contacts: Anna Sussman, 303.625.5022 asussman@clovisoncology.com orBreanna Burkart, 303.625.5023 bburkart@clovisoncology.com\nClovis Media Contacts:U.S. Lisa Guiterman, 301.217.9353 clovismedia@sambrown.com\nEurope Jake Davis, +44 (0) 20.3946.3538Jake.Davis@publicisresolute.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327266873,"gmtCreate":1616089007592,"gmtModify":1704790902513,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;Going strong.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;Going strong.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ Going strong.","images":[{"img":"https://static.tigerbbs.com/ddf7b929047dabc33ead7413ee40aedf","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327266873","isVote":1,"tweetType":1,"viewCount":590,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":327656104,"gmtCreate":1616081970208,"gmtModify":1704790798348,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;continue to hold on.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;continue to hold on.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ continue to hold on.","images":[{"img":"https://static.tigerbbs.com/4492267fd45fbbd2297355f0a8873640","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/327656104","isVote":1,"tweetType":1,"viewCount":695,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":324738992,"gmtCreate":1616029858816,"gmtModify":1704789920464,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;didn't sell when it came down to $3.15. Now is getting the reward for believing in the counter.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;didn't sell when it came down to $3.15. Now is getting the reward for believing in the counter.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ didn't sell when it came down to $3.15. Now is getting the reward for believing in the counter.","images":[{"img":"https://static.tigerbbs.com/405c7a0d3c4cd34c1aa0ffaef554795b","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/324738992","isVote":1,"tweetType":1,"viewCount":906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":325580292,"gmtCreate":1615906195216,"gmtModify":1704788328128,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ still holding on for higher.","images":[{"img":"https://static.tigerbbs.com/320d3b07ffc6d1e3739c6ead11bb7833","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325580292","isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":322987615,"gmtCreate":1615767605937,"gmtModify":1704786167889,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Hope they don't mess up the market again.&nbsp;","listText":"Hope they don't mess up the market again.&nbsp;","text":"Hope they don't mess up the market again.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322987615","repostId":"2119996708","repostType":4,"repost":{"id":"2119996708","pubTimestamp":1615765132,"share":"https://ttm.financial/m/news/2119996708?lang=&edition=fundamental","pubTime":"2021-03-15 07:38","market":"us","language":"en","title":"FOMC meeting, retail sales: What to know in the week","url":"https://stock-news.laohu8.com/highlight/detail?id=2119996708","media":"Yahoo Finance","summary":"Investors this week will be closely watching the Federal Open Market Committee's (FOMC) Wednesday mo","content":"<p>Investors this week will be closely watching the Federal Open Market Committee's (FOMC) Wednesday monetary policy decision, as well as a key report on the state of the consumer.</p><p>The FOMC's March meeting will take place Tuesday and Wednesday, with a decision set for Wednesday at 2 p.m. ET.</p><p>While this week's monetary policy decision will more than likely yield no immediate policy changes, it will take on additional weight in providing more commentary on the central bank's thinking about the pace of the economic recovery, and whether a faster-than-expected rebound might warrant a nearer-term adjustment to the Fed's policy.</p><p>In other words, Federal Reserve Chair Jerome Powell will be tasked with toeing the line between offering a more optimistic assessment of the trajectory of the economy, while also assuaging market participants' fears that the recovery may lead to overheating and a rapid rise in inflation.</p><p>\"We think it is likely that the FOMC economic forecasts will acknowledge the improved growth picture this year, and some transitory inflationary pressures as well, but will continue to show a long road toward conditions consistent with maximum employment that would put sustained pressure on inflation,\" <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> economist Ellen Zentner wrote in a note Friday.</p><p>So far, Powell and other FOMC officials have said that the Fed would leave policy as is even if the economy experiences a stint of above-target inflation, to compensate for the years of below-target inflationary pressures.</p><p>However, investors have been nervously contemplating the likelihood of an unchecked jump in inflation later this year as more businesses reopen and massive amounts of consumer demand unlock. In such a scenario, many investors have feared the Fed might react by moving faster than it has currently telegraphed by quickly raising interest rates, slowing asset purchases and otherwise tightening monetary policy to stave off inflationary pressures.</p><p>These predictions have manifested in the fixed-income markets, with the 10-year Treasury yield climbing some 50 basis points over the past month alone to more than 1.6%, both in anticipation of a strong economic recovery and of a possibly earlier than expected Fed move.</p><p>But Powell has said in recent public remarks that he believes any signs of inflation in the economy data this year would be transient. He has also maintained that the move higher in Treasury yields reflects an improving outlook on economic growth — a stance he is likely to reiterate during this week's press conference.</p><p class=\"t-img-caption\"><img src=\"https://s.yimg.com/os/creatr-uploaded-images/2020-12/98bdcfb0-453d-11eb-afbb-ec9929fbe33b\" tg-width=\"3000\" tg-height=\"2000\" referrerpolicy=\"no-referrer\"><span>Federal Reserve Chairman Jerome Powell listens to a question during a House Financial Services Committee oversight hearing to discuss the Treasury Department's and Federal Reserve's response to the coronavirus (COVID-19) pandemic on December 02, 2020 in Washington, DC.Pool via Getty Images</span></p><p>\"We do not expect a policy reaction from the FOMC with respect to ongoing volatility in the Treasury market. Chair Powell will likely highlight the Fed’s current forward guidance and flexible average inflation targeting (FAIT) for short-term rates in order to push back on current market liftoff pricing,\" Nomura economist Lewis Alexander wrote in a note.\"We expect Powell to reiterate that recent increases in long-term rates likely reflect increased optimism over the recovery, but that persistent signs of market illiquidity bear monitoring.\"</p><p>As of December, the Fed signaled it would keep the benchmark Fed funds rate at near-zero levels through at least 2023. While the Fed will likely say rates will remain on hold at least through the next two years, the central bank's updated Summary of Economic Projections this week may show <a href=\"https://laohu8.com/S/AONE\">one</a> rate hike as soon as in 2023 as economic conditions improve, some economists have speculated.</p><p>\"We do not expect any substantive changes to the Fed’s core policies — including forward guidance and asset purchases — at the March FOMC meeting,\" Alexander added. \"Additional fiscal stimulus and moderating new COVID-19 cases should strengthen the Fed’s near-term outlook. However, we believe a stronger economic outlook — including a slightly higher inflation trajectory — will result in the median 'dot' in 2023 showing <a href=\"https://laohu8.com/S/AONE.U\">one</a> rate hike.\"</p><h2>Retail sales</h2><p>One of the most closely watched economic reports this week will be the February retail sales print from the Commerce Department on Tuesday.</p><p>Consensus economists are looking for retail sales to have pulled back in February after surging by the most in seven months in January. Specifically, retail sales are expected to have fallen 0.7% month-over-month, following January's 5.3% rise.</p><p>\"The February retail sales report likely revealed a deep freeze in consumer spending,\" Bank of America economist Michelle Meyer wrote in a recent note. \"This decline reflects three main factors: 1) payback from the stimulus-induced gain in January; 2) delayed tax refunds; and 3) winter blizzard. The first two factors had a particularly negative impact on the lower income group.\"</p><p>January's retail sales report showed a strong rebound in some of the categories hardest hit during the pandemic. Department store sales spiked by nearly 24% month-over-month, bringing these stores' year-over-year sales declines to just 3%. Electronics and appliance stores also saw a nearly 15% rise in sales at the start of the year. Retail sales overall were up 7.4% year-over-year in January, extending a stretch of year-over-year gains that began last summer, as consumers increasingly spent on goods to compensate for a lack of opportunities to spend on services like leisure travel during the pandemic.</p><p>Despite the probable February drop in retail sales, the outlook for spending later this year remains strong, as a $1.9 trillion infusion of stimulus percolates through the economy and as mass vaccinations allow more spending to come back online. And consumers have been sitting on historic levels of savings as the pandemic drags out into its second year, with the personal savings rate hovering at an elevated 20.5% in January.</p><p>As in-person activities begin to reopen, the degree to which consumers reopen their wallets will depend on how they view their newly amassed capital, according to Bank of America.</p><p>“The spending multiplier will mainly depend on whether people view the money saved as ‘wealth’ or ‘deferred income.’ If it is treated like wealth, we would expect a very low payout in the order of four cents on the dollar. If it is seen as deferred income, the payout will be much higher, even if the money is mainly held by high-income households,” Ethan Harris, Bank of America head of global economics research, wrote in a note Friday. “We lean toward the latter. Therefore, we expect the glut of excess savings to help support exceptional growth this year in addition to the tailwinds from fiscal stimulus and an improving virus picture.”</p><h2>Economic calendar</h2><ul><li><p><b>Monday: </b>Empire Manufacturing, March (14.5 expected, 12.1 in February); Total Net TIC Flows, January (-$0.6 billion in December); Net Long-Term TIC Flows, January ($121.0 billion in December)</p></li><li><p><b>Tuesday: </b>Import price index, month-over-month, February (1.0% expected, 1.4% in January); Import price index excluding petroleum, February (0.4% expected, 0.9% in January); Import price index year-over-year, February (2.6% expected, 0.9% in January); Export price index, month-over-month, February (0.9% expected, 2.5% in January); Export price index, year-over-year, February (2.3% in January); Retail sales advance month-over-month, February (-0.7% expected, 5.3% in January); Retail sales excluding autos and gas, month-over-month, February (-1.3% expected, 6.1% in January); Retail sales control group, February (-1.1% expected, 6.0% in January); Industrial production month-over-month, February (0.4% expected, 0.9% in January); Capacity utilization, February (75.6% in February, 75.6% in January); Manufacturing production, February (0.2% expected, 1.0% in January); Business inventories, January (0.3% expected, 0.6% in December); NAHB Housing Market index, March (84 expected, 84 in February)</p></li><li><p><b>Wednesday: </b>MBA Mortgage Applications, week ended March 12 (-1.3% during prior week); Building permits, month-over-month, February (-7.2% expected, 10.4% in January); Housing starts, February (-1.0% expected, -6.0% in January); FOMC Rate Decision</p></li><li><p><b>Thursday: </b>Initial jobless claims, week ended March 13 (703,000 expected, 712,000 during prior week); Continuing claims, week ended March 6 (4.144 million during prior week); Philadelphia Fed Business Outlook Index, March (24.0 expected, 23.1 in February); Leading Index, February (0.3% expected, 0.5% in January)</p></li><li><p><b>Friday:</b> N/A</p></li></ul><h2>Earnings calendar</h2><ul><li><p><b>Monday: </b>N/A</p></li><li><p><b>Tuesday: </b>Coupa Software (COUP), CrowdStrike (CRWD), Lennar (LEN) after market close</p></li><li><p><b>Wednesday:</b> Green Thumb Industries (GTII.CN) after market close</p></li><li><p><b>Thursday: </b>Dollar General (DG) before market open; Nike (NKE), FedEx (FDX), Hims &amp; Hers Health (HIMS) after market close</p></li><li><p><b>Friday: </b>N/A</p></li></ul>","source":"yahoofinance_sg","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FOMC meeting, retail sales: What to know in the week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFOMC meeting, retail sales: What to know in the week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 07:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/fomc-meeting-retail-sales-what-to-know-in-the-week-ahead-151348494.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors this week will be closely watching the Federal Open Market Committee's (FOMC) Wednesday monetary policy decision, as well as a key report on the state of the consumer.The FOMC's March ...</p>\n\n<a href=\"https://finance.yahoo.com/news/fomc-meeting-retail-sales-what-to-know-in-the-week-ahead-151348494.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite","ZM":"Zoom",".SPX":"S&P 500 Index","SPY.AU":"SPDR® S&P 500® ETF Trust"},"source_url":"https://finance.yahoo.com/news/fomc-meeting-retail-sales-what-to-know-in-the-week-ahead-151348494.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119996708","content_text":"Investors this week will be closely watching the Federal Open Market Committee's (FOMC) Wednesday monetary policy decision, as well as a key report on the state of the consumer.The FOMC's March meeting will take place Tuesday and Wednesday, with a decision set for Wednesday at 2 p.m. ET.While this week's monetary policy decision will more than likely yield no immediate policy changes, it will take on additional weight in providing more commentary on the central bank's thinking about the pace of the economic recovery, and whether a faster-than-expected rebound might warrant a nearer-term adjustment to the Fed's policy.In other words, Federal Reserve Chair Jerome Powell will be tasked with toeing the line between offering a more optimistic assessment of the trajectory of the economy, while also assuaging market participants' fears that the recovery may lead to overheating and a rapid rise in inflation.\"We think it is likely that the FOMC economic forecasts will acknowledge the improved growth picture this year, and some transitory inflationary pressures as well, but will continue to show a long road toward conditions consistent with maximum employment that would put sustained pressure on inflation,\" Morgan Stanley economist Ellen Zentner wrote in a note Friday.So far, Powell and other FOMC officials have said that the Fed would leave policy as is even if the economy experiences a stint of above-target inflation, to compensate for the years of below-target inflationary pressures.However, investors have been nervously contemplating the likelihood of an unchecked jump in inflation later this year as more businesses reopen and massive amounts of consumer demand unlock. In such a scenario, many investors have feared the Fed might react by moving faster than it has currently telegraphed by quickly raising interest rates, slowing asset purchases and otherwise tightening monetary policy to stave off inflationary pressures.These predictions have manifested in the fixed-income markets, with the 10-year Treasury yield climbing some 50 basis points over the past month alone to more than 1.6%, both in anticipation of a strong economic recovery and of a possibly earlier than expected Fed move.But Powell has said in recent public remarks that he believes any signs of inflation in the economy data this year would be transient. He has also maintained that the move higher in Treasury yields reflects an improving outlook on economic growth — a stance he is likely to reiterate during this week's press conference.Federal Reserve Chairman Jerome Powell listens to a question during a House Financial Services Committee oversight hearing to discuss the Treasury Department's and Federal Reserve's response to the coronavirus (COVID-19) pandemic on December 02, 2020 in Washington, DC.Pool via Getty Images\"We do not expect a policy reaction from the FOMC with respect to ongoing volatility in the Treasury market. Chair Powell will likely highlight the Fed’s current forward guidance and flexible average inflation targeting (FAIT) for short-term rates in order to push back on current market liftoff pricing,\" Nomura economist Lewis Alexander wrote in a note.\"We expect Powell to reiterate that recent increases in long-term rates likely reflect increased optimism over the recovery, but that persistent signs of market illiquidity bear monitoring.\"As of December, the Fed signaled it would keep the benchmark Fed funds rate at near-zero levels through at least 2023. While the Fed will likely say rates will remain on hold at least through the next two years, the central bank's updated Summary of Economic Projections this week may show one rate hike as soon as in 2023 as economic conditions improve, some economists have speculated.\"We do not expect any substantive changes to the Fed’s core policies — including forward guidance and asset purchases — at the March FOMC meeting,\" Alexander added. \"Additional fiscal stimulus and moderating new COVID-19 cases should strengthen the Fed’s near-term outlook. However, we believe a stronger economic outlook — including a slightly higher inflation trajectory — will result in the median 'dot' in 2023 showing one rate hike.\"Retail salesOne of the most closely watched economic reports this week will be the February retail sales print from the Commerce Department on Tuesday.Consensus economists are looking for retail sales to have pulled back in February after surging by the most in seven months in January. Specifically, retail sales are expected to have fallen 0.7% month-over-month, following January's 5.3% rise.\"The February retail sales report likely revealed a deep freeze in consumer spending,\" Bank of America economist Michelle Meyer wrote in a recent note. \"This decline reflects three main factors: 1) payback from the stimulus-induced gain in January; 2) delayed tax refunds; and 3) winter blizzard. The first two factors had a particularly negative impact on the lower income group.\"January's retail sales report showed a strong rebound in some of the categories hardest hit during the pandemic. Department store sales spiked by nearly 24% month-over-month, bringing these stores' year-over-year sales declines to just 3%. Electronics and appliance stores also saw a nearly 15% rise in sales at the start of the year. Retail sales overall were up 7.4% year-over-year in January, extending a stretch of year-over-year gains that began last summer, as consumers increasingly spent on goods to compensate for a lack of opportunities to spend on services like leisure travel during the pandemic.Despite the probable February drop in retail sales, the outlook for spending later this year remains strong, as a $1.9 trillion infusion of stimulus percolates through the economy and as mass vaccinations allow more spending to come back online. And consumers have been sitting on historic levels of savings as the pandemic drags out into its second year, with the personal savings rate hovering at an elevated 20.5% in January.As in-person activities begin to reopen, the degree to which consumers reopen their wallets will depend on how they view their newly amassed capital, according to Bank of America.“The spending multiplier will mainly depend on whether people view the money saved as ‘wealth’ or ‘deferred income.’ If it is treated like wealth, we would expect a very low payout in the order of four cents on the dollar. If it is seen as deferred income, the payout will be much higher, even if the money is mainly held by high-income households,” Ethan Harris, Bank of America head of global economics research, wrote in a note Friday. “We lean toward the latter. Therefore, we expect the glut of excess savings to help support exceptional growth this year in addition to the tailwinds from fiscal stimulus and an improving virus picture.”Economic calendarMonday: Empire Manufacturing, March (14.5 expected, 12.1 in February); Total Net TIC Flows, January (-$0.6 billion in December); Net Long-Term TIC Flows, January ($121.0 billion in December)Tuesday: Import price index, month-over-month, February (1.0% expected, 1.4% in January); Import price index excluding petroleum, February (0.4% expected, 0.9% in January); Import price index year-over-year, February (2.6% expected, 0.9% in January); Export price index, month-over-month, February (0.9% expected, 2.5% in January); Export price index, year-over-year, February (2.3% in January); Retail sales advance month-over-month, February (-0.7% expected, 5.3% in January); Retail sales excluding autos and gas, month-over-month, February (-1.3% expected, 6.1% in January); Retail sales control group, February (-1.1% expected, 6.0% in January); Industrial production month-over-month, February (0.4% expected, 0.9% in January); Capacity utilization, February (75.6% in February, 75.6% in January); Manufacturing production, February (0.2% expected, 1.0% in January); Business inventories, January (0.3% expected, 0.6% in December); NAHB Housing Market index, March (84 expected, 84 in February)Wednesday: MBA Mortgage Applications, week ended March 12 (-1.3% during prior week); Building permits, month-over-month, February (-7.2% expected, 10.4% in January); Housing starts, February (-1.0% expected, -6.0% in January); FOMC Rate DecisionThursday: Initial jobless claims, week ended March 13 (703,000 expected, 712,000 during prior week); Continuing claims, week ended March 6 (4.144 million during prior week); Philadelphia Fed Business Outlook Index, March (24.0 expected, 23.1 in February); Leading Index, February (0.3% expected, 0.5% in January)Friday: N/AEarnings calendarMonday: N/ATuesday: Coupa Software (COUP), CrowdStrike (CRWD), Lennar (LEN) after market closeWednesday: Green Thumb Industries (GTII.CN) after market closeThursday: Dollar General (DG) before market open; Nike (NKE), FedEx (FDX), Hims & Hers Health (HIMS) after market closeFriday: N/A","news_type":1},"isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322981458,"gmtCreate":1615767411774,"gmtModify":1704786160042,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"SNDL already up a fair bit.&nbsp;","listText":"SNDL already up a fair bit.&nbsp;","text":"SNDL already up a fair bit.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322981458","repostId":"1104628946","repostType":4,"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328375207,"gmtCreate":1615503520809,"gmtModify":1704783680819,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Closed below $50.&nbsp;","listText":"Closed below $50.&nbsp;","text":"Closed below $50.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328375207","repostId":"1117588517","repostType":4,"repost":{"id":"1117588517","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615483663,"share":"https://ttm.financial/m/news/1117588517?lang=&edition=fundamental","pubTime":"2021-03-12 01:27","market":"us","language":"en","title":"Coupang spikes 85% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1117588517","media":"Tiger Newspress","summary":"Coupang shares opened at $64.8 each on Thursday, about 85% higher than the company’s IPO price.Inves","content":"<p>Coupang shares opened at $64.8&nbsp;each on Thursday, about 85% higher than the company’s IPO price.</p><p><img src=\"https://static.tigerbbs.com/6d8a7bec648b4a2f82e6b4923e6d594e\" tg-width=\"1843\" tg-height=\"913\" referrerpolicy=\"no-referrer\"></p><p>Investors looking to buy shares of South Korean e-commerce firm&nbsp;Coupang&nbsp;when it goes public in New York should consider if the company has what it takes to be profitable in the future.</p><p>That’s the advice Daniel Yoo, head of global asset allocation at Yuanta Securities, Korea, has for clients.</p><p>“What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital,” Yoo said Thursday on CNBC’s “Street Signs Asia.”</p><p>Coupang is set to debut on the New York Stock Exchange under the ticker “CPNG” later in the day when U.S. markets open.</p><p>The company said it had&nbsp;priced 130 million shares at $35 apiece, raising $4.55 billion and valuing the company around $60 billion. That makes Coupang the largest IPO in the U.S. this year and one of the&nbsp;top 25 biggest listings of all time stateside, by deal size.</p><p>The price is also above the company’s most recent&nbsp;expected range&nbsp;of between $32 and $34 a share.</p><p><b>Market leader</b></p><p>Yoo explained that the valuation and IPO price likely rose because Coupang is the only e-commerce company in South Korea that showed a sizeable gain in market share last year. He said its market size rose from 18.1% in 2019 to about 24.6% last year due to the coronavirus pandemic.</p><p>“Most of the other competitors really did not show any type of changes in terms of market share,” he said. Coupang’s rivals include eBay-owned Gmarket, WeMakePrice, Naver Shopping among others.</p><p>“The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further,” Yoo said. “It is possible that they can actually gain as much as 30%+ over the next few years.” That, he explained, would justify why the company’s IPO price has increased.</p><p>Coupang’s regulatory filing showed the company sustained losses over eight quarters through Dec. 31. But a sharp jump in sales last year helped narrow net losses from $770.2 million in 2019 to $567.6 million in 2020</p><p><b>Comparisons with Alibaba, Amazon</b></p><p>The company, whose prominent backers include SoftBank’s Vision Fund and Sequoia Capital, has drawn comparisons with&nbsp;Amazon&nbsp;and&nbsp;Alibaba. Those firms have become tech behemoths after making their public debuts.</p><p>But Yoo said that the consumer markets in the U.S. and China are significantly larger than South Korea. So, even if Coupang is able to increase its market share, he said it is unlikely to see the same kind of sales growth the other two companies saw in the last decade.</p><p>South Korea’s e-commerce market has an estimated value of $90.1 billion in 2020 with an annual growth rate of 22.3%, according to&nbsp;data analytics firm GlobalData. That is expected to grow at a compounded annual rate of 12% to reach $141.8 billion in 2024.</p><p>Spending some of its IPO proceeds on building out a strong distribution platform within Korea could benefit Coupang, according to Yoo.</p><p>The e-commerce firm was founded by Korean-American billionaire Bom Suk Kim in 2010 and is headquartered in Seoul. It has more than 100 fulfilment and logistics centers in over 30 cities that provide next-day delivery for orders placed before midnight. Coupang employs 15,000 drivers in South Korea for its deliveries and has branched out into other services such as food and grocery delivery.</p><p></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coupang spikes 85% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoupang spikes 85% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-12 01:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Coupang shares opened at $64.8&nbsp;each on Thursday, about 85% higher than the company’s IPO price.</p><p><img src=\"https://static.tigerbbs.com/6d8a7bec648b4a2f82e6b4923e6d594e\" tg-width=\"1843\" tg-height=\"913\" referrerpolicy=\"no-referrer\"></p><p>Investors looking to buy shares of South Korean e-commerce firm&nbsp;Coupang&nbsp;when it goes public in New York should consider if the company has what it takes to be profitable in the future.</p><p>That’s the advice Daniel Yoo, head of global asset allocation at Yuanta Securities, Korea, has for clients.</p><p>“What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital,” Yoo said Thursday on CNBC’s “Street Signs Asia.”</p><p>Coupang is set to debut on the New York Stock Exchange under the ticker “CPNG” later in the day when U.S. markets open.</p><p>The company said it had&nbsp;priced 130 million shares at $35 apiece, raising $4.55 billion and valuing the company around $60 billion. That makes Coupang the largest IPO in the U.S. this year and one of the&nbsp;top 25 biggest listings of all time stateside, by deal size.</p><p>The price is also above the company’s most recent&nbsp;expected range&nbsp;of between $32 and $34 a share.</p><p><b>Market leader</b></p><p>Yoo explained that the valuation and IPO price likely rose because Coupang is the only e-commerce company in South Korea that showed a sizeable gain in market share last year. He said its market size rose from 18.1% in 2019 to about 24.6% last year due to the coronavirus pandemic.</p><p>“Most of the other competitors really did not show any type of changes in terms of market share,” he said. Coupang’s rivals include eBay-owned Gmarket, WeMakePrice, Naver Shopping among others.</p><p>“The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further,” Yoo said. “It is possible that they can actually gain as much as 30%+ over the next few years.” That, he explained, would justify why the company’s IPO price has increased.</p><p>Coupang’s regulatory filing showed the company sustained losses over eight quarters through Dec. 31. But a sharp jump in sales last year helped narrow net losses from $770.2 million in 2019 to $567.6 million in 2020</p><p><b>Comparisons with Alibaba, Amazon</b></p><p>The company, whose prominent backers include SoftBank’s Vision Fund and Sequoia Capital, has drawn comparisons with&nbsp;Amazon&nbsp;and&nbsp;Alibaba. Those firms have become tech behemoths after making their public debuts.</p><p>But Yoo said that the consumer markets in the U.S. and China are significantly larger than South Korea. So, even if Coupang is able to increase its market share, he said it is unlikely to see the same kind of sales growth the other two companies saw in the last decade.</p><p>South Korea’s e-commerce market has an estimated value of $90.1 billion in 2020 with an annual growth rate of 22.3%, according to&nbsp;data analytics firm GlobalData. That is expected to grow at a compounded annual rate of 12% to reach $141.8 billion in 2024.</p><p>Spending some of its IPO proceeds on building out a strong distribution platform within Korea could benefit Coupang, according to Yoo.</p><p>The e-commerce firm was founded by Korean-American billionaire Bom Suk Kim in 2010 and is headquartered in Seoul. It has more than 100 fulfilment and logistics centers in over 30 cities that provide next-day delivery for orders placed before midnight. Coupang employs 15,000 drivers in South Korea for its deliveries and has branched out into other services such as food and grocery delivery.</p><p></p><p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPNG":"Coupang, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117588517","content_text":"Coupang shares opened at $64.8 each on Thursday, about 85% higher than the company’s IPO price.Investors looking to buy shares of South Korean e-commerce firm Coupang when it goes public in New York should consider if the company has what it takes to be profitable in the future.That’s the advice Daniel Yoo, head of global asset allocation at Yuanta Securities, Korea, has for clients.“What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital,” Yoo said Thursday on CNBC’s “Street Signs Asia.”Coupang is set to debut on the New York Stock Exchange under the ticker “CPNG” later in the day when U.S. markets open.The company said it had priced 130 million shares at $35 apiece, raising $4.55 billion and valuing the company around $60 billion. That makes Coupang the largest IPO in the U.S. this year and one of the top 25 biggest listings of all time stateside, by deal size.The price is also above the company’s most recent expected range of between $32 and $34 a share.Market leaderYoo explained that the valuation and IPO price likely rose because Coupang is the only e-commerce company in South Korea that showed a sizeable gain in market share last year. He said its market size rose from 18.1% in 2019 to about 24.6% last year due to the coronavirus pandemic.“Most of the other competitors really did not show any type of changes in terms of market share,” he said. Coupang’s rivals include eBay-owned Gmarket, WeMakePrice, Naver Shopping among others.“The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further,” Yoo said. “It is possible that they can actually gain as much as 30%+ over the next few years.” That, he explained, would justify why the company’s IPO price has increased.Coupang’s regulatory filing showed the company sustained losses over eight quarters through Dec. 31. But a sharp jump in sales last year helped narrow net losses from $770.2 million in 2019 to $567.6 million in 2020Comparisons with Alibaba, AmazonThe company, whose prominent backers include SoftBank’s Vision Fund and Sequoia Capital, has drawn comparisons with Amazon and Alibaba. Those firms have become tech behemoths after making their public debuts.But Yoo said that the consumer markets in the U.S. and China are significantly larger than South Korea. So, even if Coupang is able to increase its market share, he said it is unlikely to see the same kind of sales growth the other two companies saw in the last decade.South Korea’s e-commerce market has an estimated value of $90.1 billion in 2020 with an annual growth rate of 22.3%, according to data analytics firm GlobalData. That is expected to grow at a compounded annual rate of 12% to reach $141.8 billion in 2024.Spending some of its IPO proceeds on building out a strong distribution platform within Korea could benefit Coupang, according to Yoo.The e-commerce firm was founded by Korean-American billionaire Bom Suk Kim in 2010 and is headquartered in Seoul. It has more than 100 fulfilment and logistics centers in over 30 cities that provide next-day delivery for orders placed before midnight. Coupang employs 15,000 drivers in South Korea for its deliveries and has branched out into other services such as food and grocery delivery.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321779117,"gmtCreate":1615473204539,"gmtModify":1704783267209,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321779117","repostId":"1117372811","repostType":4,"repost":{"id":"1117372811","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615473096,"share":"https://ttm.financial/m/news/1117372811?lang=&edition=fundamental","pubTime":"2021-03-11 22:31","market":"us","language":"en","title":"Dow rises 100 points to another record, Nasdaq jumps 1.5% as tech comeback resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=1117372811","media":"Tiger Newspress","summary":"U.S. stocks climbed on Thursday led by technology stocks as investors flocked into their growth darl","content":"<p>U.S. stocks climbed on Thursday led by technology stocks as investors flocked into their growth darlings again as fears of inflation and rates eased.</p><p>The Dow Jones Industrial Average added 104 points to hit another intraday record high. The S&amp;P 500 climbed 0.7%. The Nasdaq Composite jumped 1.5% amid a rotation back into tech shares. Tesla was up 4%. Apple Facebook and Netflix all jumped at least 2%, while Amazon, Alphabet and Microsoft shares were also higher.</p><p><img src=\"https://static.tigerbbs.com/031ee8eacbecfac4e464429090ff65b6\" tg-width=\"1080\" tg-height=\"451\" referrerpolicy=\"no-referrer\"></p><p>On the data front, investors cheered a slightly better-than-expected reading on&nbsp;weekly jobless claims. The Labor Department reported that first-time filings for unemployment insurance in the week ended March 6 totaled a seasonally adjusted 712,000, below the Dow Jones estimate of 725,000.</p><p>\"The drop in jobless claims is another win for the week, and a solid sign that we're making some strides toward pre-pandemic life,\" said Mike Loewengart, managing director of investment strategy at E-Trade Financial. \"Combined with stimulus relief in sight and a muted CPI read yesterday plus increased vaccinations and decreased business restrictions, there's a pretty optimistic picture being painted.\"</p><p>The 10-year Treasury yield, which had retreated from its recent high of 1.6%, was little changed at 1.51 on Thursday.</p><p>Wednesday's gains came as the House passed the&nbsp;$1.9 trillion stimulus package, sending it to President Joe Biden, and while the bond market&nbsp;digested a $38 billion auction of 10-year Treasury bonds&nbsp;without a spike in volatility.</p><p>Rising interest rates accelerated the rotation away from tech and growth stocks in recent weeks and into more cyclical sectors, such as energy. Higher rates make profits in far-off years seem less attractive to investors and can knock down stocks with relatively high valuations.</p><p>“The faster-than-expected acceleration of U.S. economic growth appears to be lifting inflation and longer-term interest rates,” Gary Schlossberg from the Wells Fargo Investment Institute said in a note. “The pace of these increases have been a recent concern to investors, but a recovery in interest rates and inflation is a typical occurrence early in a recover – faster this time, in our opinion, because of the unusually strong economic growth rebound.”</p><p>This week has been stronger for the growth stocks overall, however, as a surge for the Nasdaq on Tuesday pulled the index out of correction territory. The&nbsp;Invesco QQQ Trust, which tracks the Nasdaq 100, is up slightly this week after falling the previous three weeks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow rises 100 points to another record, Nasdaq jumps 1.5% as tech comeback resumes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow rises 100 points to another record, Nasdaq jumps 1.5% as tech comeback resumes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-11 22:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks climbed on Thursday led by technology stocks as investors flocked into their growth darlings again as fears of inflation and rates eased.</p><p>The Dow Jones Industrial Average added 104 points to hit another intraday record high. The S&amp;P 500 climbed 0.7%. The Nasdaq Composite jumped 1.5% amid a rotation back into tech shares. Tesla was up 4%. Apple Facebook and Netflix all jumped at least 2%, while Amazon, Alphabet and Microsoft shares were also higher.</p><p><img src=\"https://static.tigerbbs.com/031ee8eacbecfac4e464429090ff65b6\" tg-width=\"1080\" tg-height=\"451\" referrerpolicy=\"no-referrer\"></p><p>On the data front, investors cheered a slightly better-than-expected reading on&nbsp;weekly jobless claims. The Labor Department reported that first-time filings for unemployment insurance in the week ended March 6 totaled a seasonally adjusted 712,000, below the Dow Jones estimate of 725,000.</p><p>\"The drop in jobless claims is another win for the week, and a solid sign that we're making some strides toward pre-pandemic life,\" said Mike Loewengart, managing director of investment strategy at E-Trade Financial. \"Combined with stimulus relief in sight and a muted CPI read yesterday plus increased vaccinations and decreased business restrictions, there's a pretty optimistic picture being painted.\"</p><p>The 10-year Treasury yield, which had retreated from its recent high of 1.6%, was little changed at 1.51 on Thursday.</p><p>Wednesday's gains came as the House passed the&nbsp;$1.9 trillion stimulus package, sending it to President Joe Biden, and while the bond market&nbsp;digested a $38 billion auction of 10-year Treasury bonds&nbsp;without a spike in volatility.</p><p>Rising interest rates accelerated the rotation away from tech and growth stocks in recent weeks and into more cyclical sectors, such as energy. Higher rates make profits in far-off years seem less attractive to investors and can knock down stocks with relatively high valuations.</p><p>“The faster-than-expected acceleration of U.S. economic growth appears to be lifting inflation and longer-term interest rates,” Gary Schlossberg from the Wells Fargo Investment Institute said in a note. “The pace of these increases have been a recent concern to investors, but a recovery in interest rates and inflation is a typical occurrence early in a recover – faster this time, in our opinion, because of the unusually strong economic growth rebound.”</p><p>This week has been stronger for the growth stocks overall, however, as a surge for the Nasdaq on Tuesday pulled the index out of correction territory. The&nbsp;Invesco QQQ Trust, which tracks the Nasdaq 100, is up slightly this week after falling the previous three weeks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117372811","content_text":"U.S. stocks climbed on Thursday led by technology stocks as investors flocked into their growth darlings again as fears of inflation and rates eased.The Dow Jones Industrial Average added 104 points to hit another intraday record high. The S&P 500 climbed 0.7%. The Nasdaq Composite jumped 1.5% amid a rotation back into tech shares. Tesla was up 4%. Apple Facebook and Netflix all jumped at least 2%, while Amazon, Alphabet and Microsoft shares were also higher.On the data front, investors cheered a slightly better-than-expected reading on weekly jobless claims. The Labor Department reported that first-time filings for unemployment insurance in the week ended March 6 totaled a seasonally adjusted 712,000, below the Dow Jones estimate of 725,000.\"The drop in jobless claims is another win for the week, and a solid sign that we're making some strides toward pre-pandemic life,\" said Mike Loewengart, managing director of investment strategy at E-Trade Financial. \"Combined with stimulus relief in sight and a muted CPI read yesterday plus increased vaccinations and decreased business restrictions, there's a pretty optimistic picture being painted.\"The 10-year Treasury yield, which had retreated from its recent high of 1.6%, was little changed at 1.51 on Thursday.Wednesday's gains came as the House passed the $1.9 trillion stimulus package, sending it to President Joe Biden, and while the bond market digested a $38 billion auction of 10-year Treasury bonds without a spike in volatility.Rising interest rates accelerated the rotation away from tech and growth stocks in recent weeks and into more cyclical sectors, such as energy. Higher rates make profits in far-off years seem less attractive to investors and can knock down stocks with relatively high valuations.“The faster-than-expected acceleration of U.S. economic growth appears to be lifting inflation and longer-term interest rates,” Gary Schlossberg from the Wells Fargo Investment Institute said in a note. “The pace of these increases have been a recent concern to investors, but a recovery in interest rates and inflation is a typical occurrence early in a recover – faster this time, in our opinion, because of the unusually strong economic growth rebound.”This week has been stronger for the growth stocks overall, however, as a surge for the Nasdaq on Tuesday pulled the index out of correction territory. The Invesco QQQ Trust, which tracks the Nasdaq 100, is up slightly this week after falling the previous three weeks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321732368,"gmtCreate":1615469380754,"gmtModify":1704783177685,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Wonder what price it will start trading when debut?&nbsp;","listText":"Wonder what price it will start trading when debut?&nbsp;","text":"Wonder what price it will start trading when debut?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321732368","repostId":"2118818339","repostType":2,"repost":{"id":"2118818339","pubTimestamp":1615461840,"share":"https://ttm.financial/m/news/2118818339?lang=&edition=fundamental","pubTime":"2021-03-11 19:24","market":"us","language":"en","title":"Softbank-backed Coupang (CPNG) Raises $4.6 Billion in the Biggest 2021 US IPO, Valued at $60 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2118818339","media":"StreetInsider","summary":"South Korean e-commerce company Coupang said it raised $4.6 billion in an initial public offering (I","content":"<html><body><div>\n<div>\n<div>\n<img src=\"https://www.streetinsider.com/images/news2/181/18112284/resize_Coupang.jpg\"/>\n</div>\n</div>\n<p>South Korean e-commerce company Coupang said it raised $4.6 billion in an initial public offering (IPO). </p><p>The company is now valued at $60 billion after it sold 130 million shares at a better-than-expected price of $35 per share. Coupang previously priced its IPO in a $32-$34 range. </p><p>“Considering the high level of valuation inherent in the pricing, the market is giving a generous assessment of the company’s achieving the top spot in market share,” said Park Sang-joon, an analyst at Kiwoom Securities.</p><p>The Coupang IPO is now the biggest US IPO this year, surpassing Bumble’s IPO. This marks a mouth-watering rise in the valuation of the ecommerce company as it was valued at $9 billion in 2019 after Softbank acquired a bigger stake in the business.</p><p>The Japanese investing bank now holds a 35.1% stake in the company that recorded a loss of $567.6 million in 2020. This is better than a loss of $770.2 million reported a year ago as the pandemic fueled a rapid rise of the e-commerce business. Coupang said its net sales exploded 91% to $11 billion last year. </p><p>“The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further. It is possible that they can actually gain as much as 30%+ over the next few years,” Daniel Yoo, head of global asset allocation at Yuanta Securities, told CNBC. </p><p>“What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital.”</p><p>Shares of the company will make a debut today on NYSE under the ticker “CPNG.”</p> </div></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Softbank-backed Coupang (CPNG) Raises $4.6 Billion in the Biggest 2021 US IPO, Valued at $60 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoftbank-backed Coupang (CPNG) Raises $4.6 Billion in the Biggest 2021 US IPO, Valued at $60 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-11 19:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18112284><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>South Korean e-commerce company Coupang said it raised $4.6 billion in an initial public offering (IPO). The company is now valued at $60 billion after it sold 130 million shares at a better-than-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18112284\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPNG":"Coupang, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=18112284","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118818339","content_text":"South Korean e-commerce company Coupang said it raised $4.6 billion in an initial public offering (IPO). The company is now valued at $60 billion after it sold 130 million shares at a better-than-expected price of $35 per share. Coupang previously priced its IPO in a $32-$34 range. “Considering the high level of valuation inherent in the pricing, the market is giving a generous assessment of the company’s achieving the top spot in market share,” said Park Sang-joon, an analyst at Kiwoom Securities.The Coupang IPO is now the biggest US IPO this year, surpassing Bumble’s IPO. This marks a mouth-watering rise in the valuation of the ecommerce company as it was valued at $9 billion in 2019 after Softbank acquired a bigger stake in the business.The Japanese investing bank now holds a 35.1% stake in the company that recorded a loss of $567.6 million in 2020. This is better than a loss of $770.2 million reported a year ago as the pandemic fueled a rapid rise of the e-commerce business. Coupang said its net sales exploded 91% to $11 billion last year. “The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further. It is possible that they can actually gain as much as 30%+ over the next few years,” Daniel Yoo, head of global asset allocation at Yuanta Securities, told CNBC. “What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital.”Shares of the company will make a debut today on NYSE under the ticker “CPNG.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321427755,"gmtCreate":1615464741877,"gmtModify":1704783100189,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Likely","listText":"Likely","text":"Likely","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/321427755","repostId":"2118603672","repostType":4,"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321427697,"gmtCreate":1615464715519,"gmtModify":1704783099052,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Me too","listText":"Me too","text":"Me too","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321427697","repostId":"1149862961","repostType":4,"repost":{"id":"1149862961","pubTimestamp":1615464666,"share":"https://ttm.financial/m/news/1149862961?lang=&edition=fundamental","pubTime":"2021-03-11 20:11","market":"us","language":"en","title":"GE signs $30 billion deal for aircraft leasing unit, but investors aren’t sold on the stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1149862961","media":"cnbc","summary":"General Electric is deep in its turnaround efforts.\nThe industrial conglomerate announced Wednesday ","content":"<div>\n<p>General Electric is deep in its turnaround efforts.\nThe industrial conglomerate announced Wednesday it would merge its aircraft leasing unit with Irish company AerCap in a deal worth $30 billion, the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/11/ge-stock-traders-weigh-in-on-companys-30b-aircraft-leasing-deal.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GE signs $30 billion deal for aircraft leasing unit, but investors aren’t sold on the stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGE signs $30 billion deal for aircraft leasing unit, but investors aren’t sold on the stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-11 20:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/11/ge-stock-traders-weigh-in-on-companys-30b-aircraft-leasing-deal.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>General Electric is deep in its turnaround efforts.\nThe industrial conglomerate announced Wednesday it would merge its aircraft leasing unit with Irish company AerCap in a deal worth $30 billion, the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/11/ge-stock-traders-weigh-in-on-companys-30b-aircraft-leasing-deal.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GE":"GE航空航天"},"source_url":"https://www.cnbc.com/2021/03/11/ge-stock-traders-weigh-in-on-companys-30b-aircraft-leasing-deal.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1149862961","content_text":"General Electric is deep in its turnaround efforts.\nThe industrial conglomerate announced Wednesday it would merge its aircraft leasing unit with Irish company AerCap in a deal worth $30 billion, the latest move to streamline the company and unload debt from its balance sheet.\nIn an interview with CNBC,CEO Larry Culp said: “GE shareholders should be delighted with this transaction. With a $30 billion headline, what we’re able to do here is bring cash in … which will allow us to put that toward additional debt reduction.”\nMichael Binger, president of Gradient Investments, applauded the company’s efforts to right the ship.\n“Culp and his predecessor Mr. Flannery have done a great job in their restructuring here. They’ve had four tasks: they’re shedding assets, they’re paying down debt, they’re focusing on their core businesses and they’re getting their underfunded pension fund healthy. I think as GE gets smaller and smaller, the market is going to like it more and more,” Binger told CNBC’s “Trading Nation” on Wednesday.\nOther recent efforts include GE’s sale of its biopharma business to Danaher and its majority divestment of oil company Baker Hughes.\nInvestors did not rally on the AerCap deal, though. GE shares tumbled 5% on Wednesday after the company also released full-year earnings guidance on the soft side.\nBinger, while confident in the restructuring plans, does not see the stock as a buy here, either.\n“Being cash flow positive is good, focusing on core positives is good, and getting down to a targeted EBITDA-to-debt level is good, but after the stock has doubled, we would not be buyers here. We would wait for lower prices before we stepped in,” he said.\nGE’s shares have rallied more than 120% in the past six months, hitting a fresh 52-week high as recently as this week.\nQuint Tatro, president of Joule Financial, is also wary of putting money to work in the stock.\n“General Electric keeps shedding businesses, albeit with good intentions to shore up that balance sheet, but they’re doing it in sectors and environments that are finally turning around. We’re seeing energy turn around. We’re seeing aircrafts coming out of Covid and the quarantine, and people are going to be traveling. So they’re selling business that I think they could be benefiting from,” Tatro said in the same interview.\nHe added that there are far better places for investors to look to instead of GE.\n“I just don’t think it’s worthy of capital here, there are too many other options. Even though it looks cheap, among a variety of metrics, I think investors need to steer clear,” Tatro said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321170987,"gmtCreate":1615417916649,"gmtModify":1704782439605,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Adding this to my tracking list ?.&nbsp;","listText":"Adding this to my tracking list ?.&nbsp;","text":"Adding this to my tracking list ?.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321170987","repostId":"1158871795","repostType":4,"repost":{"id":"1158871795","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615401200,"share":"https://ttm.financial/m/news/1158871795?lang=&edition=fundamental","pubTime":"2021-03-11 02:33","market":"us","language":"en","title":"Roblox spikes 44% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1158871795","media":"老虎资讯综合","summary":"Roblox shares opened at $65 each on Wednesday, about 44% higher than the company’sreference price.Ro","content":"<p>Roblox shares opened at $65 each on Wednesday, about 44% higher than the company’sreference price.</p><p><img src=\"https://static.tigerbbs.com/f1ba476c7f20db1e462a62e6f1df9db8\" tg-width=\"1847\" tg-height=\"904\"></p><p>Roblox Corp.  joins the ranks of closely held companies turning to public markets to support growth. The San Mateo, Calif.-based videogame provider’s stock will begin trading March 10 on the New York Stock Exchange under the symbol RBLX. The shares are trading through a direct listing, bypassing the traditional route of an initial public offering.</p><p>Roblox’s reference price was set at $45, in lieu of a formal IPO price, and is based on recent private-market transactions.</p><p>Roblox&nbsp;isn’t a traditional videogame company&nbsp;and is using a nontraditional process to potentially reach investors as the pandemic&nbsp;has driven people to spend more time and money on gameplay. Here’s what you need to know about the company and its plans for a direct listing.</p><p>Roblox said in the latest update to its&nbsp;prospectus&nbsp;that it paid developers $328.7 million last year, up almost 200% from 2019. That far outpaced the company’s sales growth of 82% last year, when it booked $923.9 million in total revenue.</p><p>More than 1,250 developers earned at least $10,000 in the digital currency Robux, which can be converted to cash. Over 300 earned $100,000 or more.</p><p>Roblox is telling prospective shareholders to get comfortable with its hefty payouts. In its&nbsp;investor presentationlast week, the company said it plans to shell out even more to creators to incentive higher-quality content and fund bigger teams of engineers, designers, artists and producers.</p><p><b>What is Roblox?</b></p><p>Roblox is a free online platform that features tens of millions of multiplayer games made by its own players with tools the company provides. The games range from obstacle-course challenges and iterations of capture the flag to contests based on popular characters such as Peppa Pig and Sonic the Hedgehog. Company officials have said they are interested in increasing the use of Roblox for things such as virtual concerts and meetings.</p><p><b>Who plays Roblox and how?</b></p><p>Roblox is accessible on computers, consoles and mobile devices. The company said it had roughly 33 million daily users last year, of whom more than half are under the age of 13. Players in Roblox appear in the form of customizable avatars.</p><p><b>Roblox’s Covid boom</b></p><p>Roblox has been a huge beneficiary of the Covid-19 shutdowns, which forced kids out of the classroom and away from their friends. With no school to attend and birthday parties canceled,kids turned to Roblox, where they can socialize virtually, navigating theme parks, attending concerts and playing action games while also staying in touch using its popular text chat feature.</p><p>Daily active users jumped 85% in 2020 to 32.6 million. The number of hours that players spent on the app more than doubled to 30.6 billion.</p><p>That unexpected and unprecedented growth has created some challenges around its developer community. The company has had to contend with an influx ofspammers&nbsp;and&nbsp;scammers&nbsp;who are out to take advantage of some of the millions of kids who are ready and willing to spend their parents money on Robux.</p><p>In-game pop-ups lure users with the promise of free Robux if they fill out a survey, only to reroute them to other sites where there’s no Robux and even more spam. In some cases, Roblox developers unknowingly install a malicious plug-in from the game development studio, infecting their own game.</p><p>“Because of the popularity of our platform, we believe that we are an attractive target for these sorts of attacks,” Roblox said in its prospectus. The company said it’s investing to make sure outside parties can’t access user data and to prevent phishing, spamming and malware as much as possible.</p><p>Roblox’s second-biggest expense, behind developer fees, is infrastructure, privacy and safety. Those costs jumped 69% last year to $264.2 million.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roblox spikes 44% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoblox spikes 44% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-11 02:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Roblox shares opened at $65 each on Wednesday, about 44% higher than the company’sreference price.</p><p><img src=\"https://static.tigerbbs.com/f1ba476c7f20db1e462a62e6f1df9db8\" tg-width=\"1847\" tg-height=\"904\"></p><p>Roblox Corp.  joins the ranks of closely held companies turning to public markets to support growth. The San Mateo, Calif.-based videogame provider’s stock will begin trading March 10 on the New York Stock Exchange under the symbol RBLX. The shares are trading through a direct listing, bypassing the traditional route of an initial public offering.</p><p>Roblox’s reference price was set at $45, in lieu of a formal IPO price, and is based on recent private-market transactions.</p><p>Roblox&nbsp;isn’t a traditional videogame company&nbsp;and is using a nontraditional process to potentially reach investors as the pandemic&nbsp;has driven people to spend more time and money on gameplay. Here’s what you need to know about the company and its plans for a direct listing.</p><p>Roblox said in the latest update to its&nbsp;prospectus&nbsp;that it paid developers $328.7 million last year, up almost 200% from 2019. That far outpaced the company’s sales growth of 82% last year, when it booked $923.9 million in total revenue.</p><p>More than 1,250 developers earned at least $10,000 in the digital currency Robux, which can be converted to cash. Over 300 earned $100,000 or more.</p><p>Roblox is telling prospective shareholders to get comfortable with its hefty payouts. In its&nbsp;investor presentationlast week, the company said it plans to shell out even more to creators to incentive higher-quality content and fund bigger teams of engineers, designers, artists and producers.</p><p><b>What is Roblox?</b></p><p>Roblox is a free online platform that features tens of millions of multiplayer games made by its own players with tools the company provides. The games range from obstacle-course challenges and iterations of capture the flag to contests based on popular characters such as Peppa Pig and Sonic the Hedgehog. Company officials have said they are interested in increasing the use of Roblox for things such as virtual concerts and meetings.</p><p><b>Who plays Roblox and how?</b></p><p>Roblox is accessible on computers, consoles and mobile devices. The company said it had roughly 33 million daily users last year, of whom more than half are under the age of 13. Players in Roblox appear in the form of customizable avatars.</p><p><b>Roblox’s Covid boom</b></p><p>Roblox has been a huge beneficiary of the Covid-19 shutdowns, which forced kids out of the classroom and away from their friends. With no school to attend and birthday parties canceled,kids turned to Roblox, where they can socialize virtually, navigating theme parks, attending concerts and playing action games while also staying in touch using its popular text chat feature.</p><p>Daily active users jumped 85% in 2020 to 32.6 million. The number of hours that players spent on the app more than doubled to 30.6 billion.</p><p>That unexpected and unprecedented growth has created some challenges around its developer community. The company has had to contend with an influx ofspammers&nbsp;and&nbsp;scammers&nbsp;who are out to take advantage of some of the millions of kids who are ready and willing to spend their parents money on Robux.</p><p>In-game pop-ups lure users with the promise of free Robux if they fill out a survey, only to reroute them to other sites where there’s no Robux and even more spam. In some cases, Roblox developers unknowingly install a malicious plug-in from the game development studio, infecting their own game.</p><p>“Because of the popularity of our platform, we believe that we are an attractive target for these sorts of attacks,” Roblox said in its prospectus. The company said it’s investing to make sure outside parties can’t access user data and to prevent phishing, spamming and malware as much as possible.</p><p>Roblox’s second-biggest expense, behind developer fees, is infrastructure, privacy and safety. Those costs jumped 69% last year to $264.2 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RBLX":"Roblox Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158871795","content_text":"Roblox shares opened at $65 each on Wednesday, about 44% higher than the company’sreference price.Roblox Corp.  joins the ranks of closely held companies turning to public markets to support growth. The San Mateo, Calif.-based videogame provider’s stock will begin trading March 10 on the New York Stock Exchange under the symbol RBLX. The shares are trading through a direct listing, bypassing the traditional route of an initial public offering.Roblox’s reference price was set at $45, in lieu of a formal IPO price, and is based on recent private-market transactions.Roblox isn’t a traditional videogame company and is using a nontraditional process to potentially reach investors as the pandemic has driven people to spend more time and money on gameplay. Here’s what you need to know about the company and its plans for a direct listing.Roblox said in the latest update to its prospectus that it paid developers $328.7 million last year, up almost 200% from 2019. That far outpaced the company’s sales growth of 82% last year, when it booked $923.9 million in total revenue.More than 1,250 developers earned at least $10,000 in the digital currency Robux, which can be converted to cash. Over 300 earned $100,000 or more.Roblox is telling prospective shareholders to get comfortable with its hefty payouts. In its investor presentationlast week, the company said it plans to shell out even more to creators to incentive higher-quality content and fund bigger teams of engineers, designers, artists and producers.What is Roblox?Roblox is a free online platform that features tens of millions of multiplayer games made by its own players with tools the company provides. The games range from obstacle-course challenges and iterations of capture the flag to contests based on popular characters such as Peppa Pig and Sonic the Hedgehog. Company officials have said they are interested in increasing the use of Roblox for things such as virtual concerts and meetings.Who plays Roblox and how?Roblox is accessible on computers, consoles and mobile devices. The company said it had roughly 33 million daily users last year, of whom more than half are under the age of 13. Players in Roblox appear in the form of customizable avatars.Roblox’s Covid boomRoblox has been a huge beneficiary of the Covid-19 shutdowns, which forced kids out of the classroom and away from their friends. With no school to attend and birthday parties canceled,kids turned to Roblox, where they can socialize virtually, navigating theme parks, attending concerts and playing action games while also staying in touch using its popular text chat feature.Daily active users jumped 85% in 2020 to 32.6 million. The number of hours that players spent on the app more than doubled to 30.6 billion.That unexpected and unprecedented growth has created some challenges around its developer community. The company has had to contend with an influx ofspammers and scammers who are out to take advantage of some of the millions of kids who are ready and willing to spend their parents money on Robux.In-game pop-ups lure users with the promise of free Robux if they fill out a survey, only to reroute them to other sites where there’s no Robux and even more spam. In some cases, Roblox developers unknowingly install a malicious plug-in from the game development studio, infecting their own game.“Because of the popularity of our platform, we believe that we are an attractive target for these sorts of attacks,” Roblox said in its prospectus. The company said it’s investing to make sure outside parties can’t access user data and to prevent phishing, spamming and malware as much as possible.Roblox’s second-biggest expense, behind developer fees, is infrastructure, privacy and safety. Those costs jumped 69% last year to $264.2 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321147850,"gmtCreate":1615417840970,"gmtModify":1704782438631,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher. I believe it can go to $4.50 range.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher. I believe it can go to $4.50 range.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ still holding on for higher. I believe it can go to $4.50 range.","images":[{"img":"https://static.tigerbbs.com/584dec794daed9b178cc217fec016db9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/321147850","isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":321030002,"gmtCreate":1615384014206,"gmtModify":1704781959702,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"?&nbsp;","listText":"?&nbsp;","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321030002","repostId":"1197220350","repostType":4,"repost":{"id":"1197220350","pubTimestamp":1615382573,"share":"https://ttm.financial/m/news/1197220350?lang=&edition=fundamental","pubTime":"2021-03-10 21:22","market":"us","language":"en","title":"The stimulus money isn’t going to be spent, Bank of America says, so here are the investment moves to make","url":"https://stock-news.laohu8.com/highlight/detail?id=1197220350","media":"MarketWatch","summary":"Critical information for the trading day\nThe big talk not just in markets but in politics is whether","content":"<p>Critical information for the trading day</p>\n<p>The big talk not just in markets but in politics is whether the new round of stimulus will overheat the economy.</p>\n<p>Bank of America’s research investment committee say it won’t, and brings some new data to the table. First, itcited data from the Census Bureaushowing that of the households who received a $600 stimulus check in the first half of February, 73% saved or paid down debt.Consumer credit also unexpectedly fellin January.</p>\n<p><img src=\"https://static.tigerbbs.com/a9e3334cb85210766345c791422c52a4\" tg-width=\"619\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p>\n<p>Bank of America also surveyed more than 3,000 people to ask how they would spend the new stimulus check. Even in the lowest-income category, 53% say they plan to either save, pay off debts or invest.</p>\n<p>So what does that mean for investors? Bank of America says don’t count on anything more than a temporary inflation rebound. Supply disruptions will be relieved as the labor force returns to work, plus progress on artificial intelligence and automation could mean fewer industrial jobs to return to. If wage growth does accelerate, companies can afford to accelerate research and development.</p>\n<p>The research investment committee recommends what it calls prudent yield for bond allocations — high-yield corporate and municipal bonds, leveraged loans, preferred stock and convertible bonds have all outperformed the overall bond market. For stocks, it says buy small-cap growth when it dips, and the Nasdaq CompositeCOMP,+3.69%at 11,600 (which is 12% below Tuesday’s close).</p>\n<p>Financials are its favorite sector since it can win either way. If Bank of America’s inflation analysis is wrong, banks would benefit from a steeper yield curve and more housing and loan activity. If it is right, banks would be attractive, given higher stock buybacks and attractive yields.</p>\n<p><b>The buzz</b></p>\n<p>The House of Representatives is due to vote on the $1.9 trillion stimulus plan already approved by the U.S. Senate, at which point it will head to the White House for President Joe Biden’s signature. TheCongressional Budget Office estimates $1.1 trillion will be spent in 2021.</p>\n<p>U.S. consumer price data for February will be the focus of a market suddenly obsessed with the prospect of inflation breaking out.</p>\n<p>Maryland become thelatest state to relax many of its COVID-19 restrictions.</p>\n<p>The U.S. and China are discussing sending their top diplomats to Alaska in a bid to reset relations for the Biden administration,according to the South China Morning Post.</p>\n<p>PfizerPFE,+0.29%and BioNTechBNTX,+6.86%agreed to provide 4 million extra coroanvirus vaccine doses to the European Union.</p>\n<p>Roblox Corp.scored a reference price of $45 a share from the New York Stock Exchange as the tween-centric gaming platform prepares to go public through a direct listing on Wednesday.</p>\n<p>Luxury home builder Toll BrothersTOL,-0.43%reported a 70% jump in its first-quarter profit.</p>\n<p><b>The market</b></p>\n<p>After Tuesday’s big surge in technology stocks and bonds, it was looking calmer in the early going. U.S. stock futuresES00,-0.06%NQ00,-0.40%dipped slightly, and the yield on the 10-year TreasuryTMUBMUSD10Y,1.562%edged up to 1.56%.</p>\n<p>Bitcoin futuresBTC.1,+2.42%climbed over $55,000.</p>\n<p><b>The chart</b></p>\n<p><img src=\"https://static.tigerbbs.com/f31e46e6528fc893194850ac08ca2a74\" tg-width=\"620\" tg-height=\"335\" referrerpolicy=\"no-referrer\"></p>\n<p>Portfolio strategists at Bernstein Research carved the economic cycle into four different parts and tested how well different investment style factors fared. Value stocks did best in the current “recovery” part of the economic cycle.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The stimulus money isn’t going to be spent, Bank of America says, so here are the investment moves to make</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe stimulus money isn’t going to be spent, Bank of America says, so here are the investment moves to make\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-10 21:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/the-stimulus-money-isnt-going-to-be-spent-bank-of-america-says-so-here-are-the-investment-moves-to-make-11615376336?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Critical information for the trading day\nThe big talk not just in markets but in politics is whether the new round of stimulus will overheat the economy.\nBank of America’s research investment ...</p>\n\n<a href=\"https://www.marketwatch.com/story/the-stimulus-money-isnt-going-to-be-spent-bank-of-america-says-so-here-are-the-investment-moves-to-make-11615376336?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/the-stimulus-money-isnt-going-to-be-spent-bank-of-america-says-so-here-are-the-investment-moves-to-make-11615376336?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1197220350","content_text":"Critical information for the trading day\nThe big talk not just in markets but in politics is whether the new round of stimulus will overheat the economy.\nBank of America’s research investment committee say it won’t, and brings some new data to the table. First, itcited data from the Census Bureaushowing that of the households who received a $600 stimulus check in the first half of February, 73% saved or paid down debt.Consumer credit also unexpectedly fellin January.\n\nBank of America also surveyed more than 3,000 people to ask how they would spend the new stimulus check. Even in the lowest-income category, 53% say they plan to either save, pay off debts or invest.\nSo what does that mean for investors? Bank of America says don’t count on anything more than a temporary inflation rebound. Supply disruptions will be relieved as the labor force returns to work, plus progress on artificial intelligence and automation could mean fewer industrial jobs to return to. If wage growth does accelerate, companies can afford to accelerate research and development.\nThe research investment committee recommends what it calls prudent yield for bond allocations — high-yield corporate and municipal bonds, leveraged loans, preferred stock and convertible bonds have all outperformed the overall bond market. For stocks, it says buy small-cap growth when it dips, and the Nasdaq CompositeCOMP,+3.69%at 11,600 (which is 12% below Tuesday’s close).\nFinancials are its favorite sector since it can win either way. If Bank of America’s inflation analysis is wrong, banks would benefit from a steeper yield curve and more housing and loan activity. If it is right, banks would be attractive, given higher stock buybacks and attractive yields.\nThe buzz\nThe House of Representatives is due to vote on the $1.9 trillion stimulus plan already approved by the U.S. Senate, at which point it will head to the White House for President Joe Biden’s signature. TheCongressional Budget Office estimates $1.1 trillion will be spent in 2021.\nU.S. consumer price data for February will be the focus of a market suddenly obsessed with the prospect of inflation breaking out.\nMaryland become thelatest state to relax many of its COVID-19 restrictions.\nThe U.S. and China are discussing sending their top diplomats to Alaska in a bid to reset relations for the Biden administration,according to the South China Morning Post.\nPfizerPFE,+0.29%and BioNTechBNTX,+6.86%agreed to provide 4 million extra coroanvirus vaccine doses to the European Union.\nRoblox Corp.scored a reference price of $45 a share from the New York Stock Exchange as the tween-centric gaming platform prepares to go public through a direct listing on Wednesday.\nLuxury home builder Toll BrothersTOL,-0.43%reported a 70% jump in its first-quarter profit.\nThe market\nAfter Tuesday’s big surge in technology stocks and bonds, it was looking calmer in the early going. U.S. stock futuresES00,-0.06%NQ00,-0.40%dipped slightly, and the yield on the 10-year TreasuryTMUBMUSD10Y,1.562%edged up to 1.56%.\nBitcoin futuresBTC.1,+2.42%climbed over $55,000.\nThe chart\n\nPortfolio strategists at Bernstein Research carved the economic cycle into four different parts and tested how well different investment style factors fared. Value stocks did best in the current “recovery” part of the economic cycle.","news_type":1},"isVote":1,"tweetType":1,"viewCount":58,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":365762240487672,"gmtCreate":1730298098561,"gmtModify":1730298102275,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$&nbsp;</a> With the resignation from EY, it shows the corporate governance concern is real. I will stay away for now until it has been clean up. Possible to go down to $20 range.","listText":"<a href=\"https://ttm.financial/S/SMCI\">$SUPER MICRO COMPUTER INC(SMCI)$&nbsp;</a> With the resignation from EY, it shows the corporate governance concern is real. I will stay away for now until it has been clean up. Possible to go down to $20 range.","text":"$SUPER MICRO COMPUTER INC(SMCI)$ With the resignation from EY, it shows the corporate governance concern is real. I will stay away for now until it has been clean up. Possible to go down to $20 range.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":2,"link":"https://ttm.financial/post/365762240487672","isVote":1,"tweetType":1,"viewCount":1813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327656104,"gmtCreate":1616081970208,"gmtModify":1704790798348,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;continue to hold on.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;continue to hold on.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ continue to hold on.","images":[{"img":"https://static.tigerbbs.com/4492267fd45fbbd2297355f0a8873640","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/327656104","isVote":1,"tweetType":1,"viewCount":695,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":321147850,"gmtCreate":1615417840970,"gmtModify":1704782438631,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher. I believe it can go to $4.50 range.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher. I believe it can go to $4.50 range.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ still holding on for higher. I believe it can go to $4.50 range.","images":[{"img":"https://static.tigerbbs.com/584dec794daed9b178cc217fec016db9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/321147850","isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":320193517,"gmtCreate":1615034641439,"gmtModify":1704778309419,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CFMS\">$ConforMIS(CFMS)$</a>&nbsp;going to be positive + next week. Looking forward. ??️","listText":"<a href=\"https://laohu8.com/S/CFMS\">$ConforMIS(CFMS)$</a>&nbsp;going to be positive + next week. Looking forward. ??️","text":"$ConforMIS(CFMS)$ going to be positive + next week. Looking forward. ??️","images":[{"img":"https://static.tigerbbs.com/570cc5fbf6adcd7d4868d417b92663d7","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/320193517","isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":356167541,"gmtCreate":1616765620383,"gmtModify":1704798577803,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Cathie Wood herself has been bullish else she won't have invested recently.&nbsp;","listText":"Cathie Wood herself has been bullish else she won't have invested recently.&nbsp;","text":"Cathie Wood herself has been bullish else she won't have invested recently.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/356167541","repostId":"1160686264","repostType":4,"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329246677,"gmtCreate":1615254171299,"gmtModify":1704780150383,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Let the rally continue.&nbsp;","listText":"Let the rally continue.&nbsp;","text":"Let the rally continue.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/329246677","repostId":"1131741020","repostType":4,"repost":{"id":"1131741020","pubTimestamp":1615248872,"share":"https://ttm.financial/m/news/1131741020?lang=&edition=fundamental","pubTime":"2021-03-09 08:14","market":"us","language":"en","title":"Dow rises 300 points to touch a record, Nasdaq sheds 2% as rotation out of tech continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1131741020","media":"cnbc","summary":"The Dow Jones Industrial Average climbed on Monday as investors piled into economic comeback plays a","content":"<div>\n<p>The Dow Jones Industrial Average climbed on Monday as investors piled into economic comeback plays after Senate approval of a new Covid stimulus package, while a continuous sell-off in high-flying ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/07/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow rises 300 points to touch a record, Nasdaq sheds 2% as rotation out of tech continues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow rises 300 points to touch a record, Nasdaq sheds 2% as rotation out of tech continues\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-09 08:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/07/stock-market-open-to-close-news.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average climbed on Monday as investors piled into economic comeback plays after Senate approval of a new Covid stimulus package, while a continuous sell-off in high-flying ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/07/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/03/07/stock-market-open-to-close-news.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131741020","content_text":"The Dow Jones Industrial Average climbed on Monday as investors piled into economic comeback plays after Senate approval of a new Covid stimulus package, while a continuous sell-off in high-flying tech shares put pressure on the broader market.\nThe blue-chip benchmark gained 306.14 points, or 1%, to 31,802.44 led by Disney. At its session high, the 30-stock average jumped 650 points to hit an intraday record high. The S&P 500 erased a 1% gain to close 0.5% lower at 3,821.35. The Nasdaq Composite slid 2.4% in volatile trading to 12,609.16 as Apple dropped 4.2% and Tesla fell 5.8%. Alphabet and Netflix both slipped more than 4%.\nThe tech-heavy benchmark closed more than 10% below its Feb.12 closing high, falling into correction territory.\nThe Senate passed a$1.9 trillion economic relief and stimulus bill on Saturday, paving the way for extensions to unemployment benefits, another round of stimulus checks and aid to state and local governments. The Democrat-controlled House is expected to pass the bill later this week. President Joe Biden is expected to sign it into law before unemployment aid programs expire on March 14.\nMeanwhile, the Centers for Disease Control and Prevention said Monday people who've been fully vaccinated against Covid-19can meet safely indoors without masks, further boosting reopening hopes. The positive news boosted stocks banking on a strong economic recovery.\nDisney shares added more than 6% afterCalifornia eased Covid rules, paving the way for Disneyland to reopen on a limited basis in April. American Airlines jumped nearly 5%, while United Airlines popped 7%. Target rose 2.5%.\n\"More stimulus could provide a big lift to the stock market, but it may come with some bumps,\" said Lindsey Bell, chief investment strategist at Ally Invest. \"Runaway inflation worries have been a stumbling block for stocks as of late. Because of this, there could be more market weakness ahead as investors grapple with the short- and long-term effects of stimulus. High-flying stocks like tech and the 'stay at home' stocks may be hit the hardest.\"\nTech stocks remained the biggest losers on Monday, continuing the trend for the last few weeks. High-growth stocks, which were among the best performers last year, are particularly vulnerable as higher rates reduce the value of future cash flows.\nApple has fallen 15% in the past month, while Tesla has dropped 34% in that period. Pandemic bets Zoom Video and Peloton have tumbled 24% and 30% over the past month.\nSentiment got a boost earlier Monday afterhedge fund manager David Tepper said the recent sharp rise in rates is likely overand it's hard to be bearish on stocks right now.\n\"Basically I think rates have temporarily made the most of the move and should be more stable in the next few months, which makes it safer to be in stocks for now,\" Tepper told CNBC's Joe Kernen, who shared the comments on \"Squawk Box.\"\nThe benchmark 10-year yield has risen sharply in recent weeks in anticipation of more stimulus on top of a booming economic recovery. The10-year Treasury yieldrose 4 basis points to 1.6% Monday. The benchmark rate started the calendar year below the 1% mark.\nTepper believes the sell-off in Treasurys that has driven rates higher is likely over as big foreign buyers like Japan are poised to come in. He also said \"bellwether\" stocks like Amazon are starting to look attractive after the pullback. Amazon shares have fallen 11% over the past month.\nThe market rotation has created a big divergence among the major averages. For March, the Dow Industrials, leveraged more to the reopening, is up 2.8%, while the Nasdaq Composite is off by 4.4%. Meanwhile, the broader S&P 500 is up 0.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":29,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":324738992,"gmtCreate":1616029858816,"gmtModify":1704789920464,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;didn't sell when it came down to $3.15. Now is getting the reward for believing in the counter.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;didn't sell when it came down to $3.15. Now is getting the reward for believing in the counter.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ didn't sell when it came down to $3.15. Now is getting the reward for believing in the counter.","images":[{"img":"https://static.tigerbbs.com/405c7a0d3c4cd34c1aa0ffaef554795b","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/324738992","isVote":1,"tweetType":1,"viewCount":906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":320560024,"gmtCreate":1615158124068,"gmtModify":1704778894245,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Tesla price is too high and I can't imaging those bought at 800 per shares still have the big heart for it to bounce back. This week will be crucial for Tesla cause if it break downward 500, is going to be interesting.&nbsp;","listText":"Tesla price is too high and I can't imaging those bought at 800 per shares still have the big heart for it to bounce back. This week will be crucial for Tesla cause if it break downward 500, is going to be interesting.&nbsp;","text":"Tesla price is too high and I can't imaging those bought at 800 per shares still have the big heart for it to bounce back. This week will be crucial for Tesla cause if it break downward 500, is going to be interesting.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320560024","repostId":"2117062475","repostType":2,"repost":{"id":"2117062475","pubTimestamp":1614867646,"share":"https://ttm.financial/m/news/2117062475?lang=&edition=fundamental","pubTime":"2021-03-04 22:20","market":"us","language":"en","title":"Tesla Megabull Ron Baron Says It Was 'Painful' To Sell 1.7M Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2117062475","media":"Benzinga","summary":"Longtime Tesla Inc (NASDAQ: TSLA) bull Ron Baron acknowledged Thursday morning his fund Baron Capita","content":"<html><body><img height=\"400\" src=\"https://s1.yimg.com/uu/api/res/1.2/NLsGepPJz3DgBfWCmTbihA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/Benzinga/8e87a6f1ea9af17ed3578df611cfd3c9\" title=\"\" width=\"600\"/>\n<p>Longtime <strong>Tesla Inc</strong> (NASDAQ: TSLA) bull Ron Baron acknowledged Thursday morning his fund Baron Capital sold 1.7 million shares of the electric automaker despite his long-held belief the stock has a path to $2,000.</p>\n<p><strong>What Happened:</strong> Baron Capital invested $387 million in Tesla's stock back in 2014 and the position has grown to be worth $5.5 billion in February, Baron said on CNBC's \"Squawk Box.\" Over the past six months, the fund has sold 1.7 million out of its 8-million share position between $450 and $900 a share with an average price of $666.70.</p>\n<p>Baron said many of his friends were skeptical with his original 2014 thesis that Tesla's stock would return 20 times.</p>\n<p>\"We persisted,\" Baron said. \"And at the time we invested, it was unlikely in most people's opinions that electric cars were going to dominate.\"</p>\n<p><em>Related Link: Ark More Convinced On Tesla's Autonomous Strategy And Cathie Wood Says A New Price Target Is Coming Soon</em></p>\n<p><strong>Why It's Important:</strong> The decision to authorize a sale of a stock he believes still has tremendous upside potential was due strictly to profit-taking as the stock's surge means it accounted for an outsized representation in the fund portfolio, Baron said. The fund also used some of the proceeds from the sale to pay down part of a line of credit.</p>\n<p>Baron said it was \"painful\" to sell close to 2 million shares of Tesla's stock as the company's prospects of eventually selling 20 million cars a year is a more realistic outcome. Tesla has so many opportunities ahead, such as the ability to monetize each of the 20 million cars sold by charging a monthly $100 fee for autonomous driving features.</p>\n<p>\"That alone is worth the present price of the stock in 10 years,\" he said.</p>\n<p><em>See also: How to Invest in Tesla Stock</em></p>\n<p><strong>What's Next:</strong> The billionaire himself said he has not sold a single share he personally owns and is unlikely to do so \"for another 10 years.\"</p>\n<p>Tesla's stock traded around $657 a share at publication time.</p>\n<p><strong>See more from Benzinga</strong></p>\n<ul>\n<li>Click here for options trades from Benzinga</li>\n<li>Exclusive: Grayscale CEO 'Wouldn't Rule Out' Future Bitcoin ETF Launch In US</li>\n</ul>\n<p><i>© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</i></p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Megabull Ron Baron Says It Was 'Painful' To Sell 1.7M Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Megabull Ron Baron Says It Was 'Painful' To Sell 1.7M Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-04 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/tesla-megabull-ron-baron-says-142046385.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Longtime Tesla Inc (NASDAQ: TSLA) bull Ron Baron acknowledged Thursday morning his fund Baron Capital sold 1.7 million shares of the electric automaker despite his long-held belief the stock has a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tesla-megabull-ron-baron-says-142046385.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/zeXumK6h5sKoGGumZtM0fg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/TYDG2Ev2x4ReKVsYu.aq0g--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/8e87a6f1ea9af17ed3578df611cfd3c9","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/tesla-megabull-ron-baron-says-142046385.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2117062475","content_text":"Longtime Tesla Inc (NASDAQ: TSLA) bull Ron Baron acknowledged Thursday morning his fund Baron Capital sold 1.7 million shares of the electric automaker despite his long-held belief the stock has a path to $2,000.\nWhat Happened: Baron Capital invested $387 million in Tesla's stock back in 2014 and the position has grown to be worth $5.5 billion in February, Baron said on CNBC's \"Squawk Box.\" Over the past six months, the fund has sold 1.7 million out of its 8-million share position between $450 and $900 a share with an average price of $666.70.\nBaron said many of his friends were skeptical with his original 2014 thesis that Tesla's stock would return 20 times.\n\"We persisted,\" Baron said. \"And at the time we invested, it was unlikely in most people's opinions that electric cars were going to dominate.\"\nRelated Link: Ark More Convinced On Tesla's Autonomous Strategy And Cathie Wood Says A New Price Target Is Coming Soon\nWhy It's Important: The decision to authorize a sale of a stock he believes still has tremendous upside potential was due strictly to profit-taking as the stock's surge means it accounted for an outsized representation in the fund portfolio, Baron said. The fund also used some of the proceeds from the sale to pay down part of a line of credit.\nBaron said it was \"painful\" to sell close to 2 million shares of Tesla's stock as the company's prospects of eventually selling 20 million cars a year is a more realistic outcome. Tesla has so many opportunities ahead, such as the ability to monetize each of the 20 million cars sold by charging a monthly $100 fee for autonomous driving features.\n\"That alone is worth the present price of the stock in 10 years,\" he said.\nSee also: How to Invest in Tesla Stock\nWhat's Next: The billionaire himself said he has not sold a single share he personally owns and is unlikely to do so \"for another 10 years.\"\nTesla's stock traded around $657 a share at publication time.\nSee more from Benzinga\n\nClick here for options trades from Benzinga\nExclusive: Grayscale CEO 'Wouldn't Rule Out' Future Bitcoin ETF Launch In US\n\n© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.","news_type":1},"isVote":1,"tweetType":1,"viewCount":71,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327266873,"gmtCreate":1616089007592,"gmtModify":1704790902513,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;Going strong.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;Going strong.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ Going strong.","images":[{"img":"https://static.tigerbbs.com/ddf7b929047dabc33ead7413ee40aedf","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327266873","isVote":1,"tweetType":1,"viewCount":590,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":321097259,"gmtCreate":1615383973271,"gmtModify":1704781959053,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Any view if is a good buy now?&nbsp;","listText":"Any view if is a good buy now?&nbsp;","text":"Any view if is a good buy now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/321097259","repostId":"2118367618","repostType":4,"repost":{"id":"2118367618","pubTimestamp":1615382781,"share":"https://ttm.financial/m/news/2118367618?lang=&edition=fundamental","pubTime":"2021-03-10 21:26","market":"us","language":"en","title":"Should You Buy Moderna in March?","url":"https://stock-news.laohu8.com/highlight/detail?id=2118367618","media":"Motley Fool","summary":"The stock is down big, but the company is coming off of an improved fourth quarter.","content":"<p>The stock is down big, but the company is coming off of an improved fourth quarter.</p>\n<p><b>Moderna</b>&nbsp;(NASDAQ:MRNA) has been <a href=\"https://laohu8.com/S/AONE\">one</a> of the hottest stocks to buy over the past year, soaring more than 340% while the<b>S&amp;P 500</b> has increased by just 30% during that time. The company's COVID-19 vaccine has put Moderna on the map with investors, sending its market cap from less than $10 billion to more than $52 billion. And if its CEO is right about COVID-19 being around forever, the vaccine could deliver recurring income for many years.</p>\n<p>However, Moderna's shares have been crashing over the past month despite a strong earnings report. Is March a good time to load up on the stock or should investors wait for more of a dip in price before investing in the company?</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/52d3762c89c18ae11c55b6954c91692b\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<p><b>A lot depends on the future of COVID-19</b></p>\n<p>Moderna's vaccine for COVID-19, mRNA-1273, has significant sales potential. The company expects the vaccine (which is also the first product Moderna's ever brought to market) will generate a staggering $18.4 billion in revenue in 2021. Those numbers would blow past Moderna's 2020 revenue, which at $803.4 million was already 13 times higher than 2019's top line of $60.2 million.</p>\n<p>Whether you think Moderna is a buy or not will likely come down to your outlook for the pandemic. If you anticipate that it will be around for the long term, then Moderna could certainly play a big role in containing the coronavirus. However, there is also the risk is that as more companies get the nod from the U.S. Food and Drug Administration (FDA) for their vaccines, there will also be more options for health officials to choose from, which will chip away at Moderna's market share.</p>\n<p>The FDA granted&nbsp;<b>Johnson &amp; Johnson</b>'s single-dose vaccine Emergency Use Authorization (EUA) on Feb. 27, making it the third vaccine that will now be available in the U.S., in addition to those from Moderna and&nbsp;<b>Pfizer</b>.<b>AstraZeneca</b>&nbsp;anticipates the FDA will issue its vaccine EUA in April while&nbsp;<b>Novavax</b>&nbsp;projects it will get the green light in May.</p>\n<p>But Moderna's vaccine doesn't need to be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the only two or three options to generate significant sales. Even if it generated half of that $18 billion on a recurring basis (perhaps through booster shots to treat variants of COVID-19), that along with other products in the pipeline could make it a formidable healthcare investment worth hanging on to.</p>\n<p>One of the most promising vaccines in its pipeline today is mRNA-1647, which is for cytomegalovirus (CMV). On Feb. 25, when the company released its fourth-quarter earnings for the period ending Dec. 31, 2020, Moderna said its phase 3 study for the drug would begin \"soon.\"&nbsp;But even that vaccine, at its peak, could generate between $2 billion and $5 billion in sales for the company -- a small fraction of what Moderna looks to make from mRNA-1273.&nbsp;The company also has a vaccine for the Zika virus that is still in its early stages and that could be a \"several hundred-million-dollar annual peak sales opportunity.\"</p>\n<p>The business isn't<i>entirely</i> dependent on COVID-19, but the outlook for the pandemic definitely factors into the stock's hefty valuation; the worse it is, the more valuable Moderna becomes.</p>\n<p><b>Moderna's stock is cheap(er) -- but is it low enough to buy?</b></p>\n<p>Although Moderna is coming off a strong fourth quarter, where sales came in at $570.7 million (compared to just $14.1 million in the prior-year period), its shares have fallen more than 30% in just the past month while the S&amp;P 500 is down just 1%. That is likely to do with a more favorable view of the pandemic and hope that things could soon be getting back to normal, especially now that President Joe Biden anticipates that by the end of May, there will have been enough vaccines available to inoculate all adults in the U.S.</p>\n<p>Moderna's price today isn't anywhere near its 52-week lows or even close to $100 -- which it nearly fell to at the end of 2020. However, when looking at its forward price-to-sales (P/S) ratio, there does appear to be some great hidden value here:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2a409236ba53d13b1fe3d70f82010eb7\" tg-width=\"720\" tg-height=\"387\"><span>MRNA PS Ratio (Forward) data by YCharts</span></p>\n<p>Moderna compares well against the other COVID-19 stocks mentioned earlier as its future revenue from mRNA-1273 makes its valuation look attractive.</p>\n<p><b>Should you buy Moderna stock?</b></p>\n<p>With a low P/S multiple and a good year ahead, Moderna's stock could potentially make for a solid investment. I wouldn't go so far as to say it is a great<i>long-term</i>investment, only because there are too many question marks surrounding COVID-19 in the years ahead. That includes whether mRNA-1273 will be needed beyond this year, if booster shots will be required to maintain immunity, and, ultimately, how much money the company might generate from pandemic-related revenue. Those are all variables that are unknowns right now and that makes it difficult to predict if Moderna is worth hanging on to over the long term.</p>\n<p>The stock looks great, potentially for the next several months, or even the entire year. But beyond that, it becomes a riskier buy. So, while its share price is lower in March, long-term investors may still want to see the stock fall even further (perhaps below $100) before Moderna's stock is cheap enough that it makes up for some of that risk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should You Buy Moderna in March?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould You Buy Moderna in March?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-10 21:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/10/should-you-buy-moderna-in-march/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock is down big, but the company is coming off of an improved fourth quarter.\nModerna (NASDAQ:MRNA) has been one of the hottest stocks to buy over the past year, soaring more than 340% while ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/10/should-you-buy-moderna-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/03/10/should-you-buy-moderna-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118367618","content_text":"The stock is down big, but the company is coming off of an improved fourth quarter.\nModerna (NASDAQ:MRNA) has been one of the hottest stocks to buy over the past year, soaring more than 340% while theS&P 500 has increased by just 30% during that time. The company's COVID-19 vaccine has put Moderna on the map with investors, sending its market cap from less than $10 billion to more than $52 billion. And if its CEO is right about COVID-19 being around forever, the vaccine could deliver recurring income for many years.\nHowever, Moderna's shares have been crashing over the past month despite a strong earnings report. Is March a good time to load up on the stock or should investors wait for more of a dip in price before investing in the company?\nImage source: Getty Images.\nA lot depends on the future of COVID-19\nModerna's vaccine for COVID-19, mRNA-1273, has significant sales potential. The company expects the vaccine (which is also the first product Moderna's ever brought to market) will generate a staggering $18.4 billion in revenue in 2021. Those numbers would blow past Moderna's 2020 revenue, which at $803.4 million was already 13 times higher than 2019's top line of $60.2 million.\nWhether you think Moderna is a buy or not will likely come down to your outlook for the pandemic. If you anticipate that it will be around for the long term, then Moderna could certainly play a big role in containing the coronavirus. However, there is also the risk is that as more companies get the nod from the U.S. Food and Drug Administration (FDA) for their vaccines, there will also be more options for health officials to choose from, which will chip away at Moderna's market share.\nThe FDA granted Johnson & Johnson's single-dose vaccine Emergency Use Authorization (EUA) on Feb. 27, making it the third vaccine that will now be available in the U.S., in addition to those from Moderna and Pfizer.AstraZeneca anticipates the FDA will issue its vaccine EUA in April while Novavax projects it will get the green light in May.\nBut Moderna's vaccine doesn't need to be one of the only two or three options to generate significant sales. Even if it generated half of that $18 billion on a recurring basis (perhaps through booster shots to treat variants of COVID-19), that along with other products in the pipeline could make it a formidable healthcare investment worth hanging on to.\nOne of the most promising vaccines in its pipeline today is mRNA-1647, which is for cytomegalovirus (CMV). On Feb. 25, when the company released its fourth-quarter earnings for the period ending Dec. 31, 2020, Moderna said its phase 3 study for the drug would begin \"soon.\" But even that vaccine, at its peak, could generate between $2 billion and $5 billion in sales for the company -- a small fraction of what Moderna looks to make from mRNA-1273. The company also has a vaccine for the Zika virus that is still in its early stages and that could be a \"several hundred-million-dollar annual peak sales opportunity.\"\nThe business isn'tentirely dependent on COVID-19, but the outlook for the pandemic definitely factors into the stock's hefty valuation; the worse it is, the more valuable Moderna becomes.\nModerna's stock is cheap(er) -- but is it low enough to buy?\nAlthough Moderna is coming off a strong fourth quarter, where sales came in at $570.7 million (compared to just $14.1 million in the prior-year period), its shares have fallen more than 30% in just the past month while the S&P 500 is down just 1%. That is likely to do with a more favorable view of the pandemic and hope that things could soon be getting back to normal, especially now that President Joe Biden anticipates that by the end of May, there will have been enough vaccines available to inoculate all adults in the U.S.\nModerna's price today isn't anywhere near its 52-week lows or even close to $100 -- which it nearly fell to at the end of 2020. However, when looking at its forward price-to-sales (P/S) ratio, there does appear to be some great hidden value here:\nMRNA PS Ratio (Forward) data by YCharts\nModerna compares well against the other COVID-19 stocks mentioned earlier as its future revenue from mRNA-1273 makes its valuation look attractive.\nShould you buy Moderna stock?\nWith a low P/S multiple and a good year ahead, Moderna's stock could potentially make for a solid investment. I wouldn't go so far as to say it is a greatlong-terminvestment, only because there are too many question marks surrounding COVID-19 in the years ahead. That includes whether mRNA-1273 will be needed beyond this year, if booster shots will be required to maintain immunity, and, ultimately, how much money the company might generate from pandemic-related revenue. Those are all variables that are unknowns right now and that makes it difficult to predict if Moderna is worth hanging on to over the long term.\nThe stock looks great, potentially for the next several months, or even the entire year. But beyond that, it becomes a riskier buy. So, while its share price is lower in March, long-term investors may still want to see the stock fall even further (perhaps below $100) before Moderna's stock is cheap enough that it makes up for some of that risk.","news_type":1},"isVote":1,"tweetType":1,"viewCount":53,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365052186,"gmtCreate":1614682797645,"gmtModify":1704773957964,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CFMS\">$ConforMIS(CFMS)$</a>&nbsp;Bought a bit to see if it can give some pocket money later ?.&nbsp;","listText":"<a href=\"https://laohu8.com/S/CFMS\">$ConforMIS(CFMS)$</a>&nbsp;Bought a bit to see if it can give some pocket money later ?.&nbsp;","text":"$ConforMIS(CFMS)$ Bought a bit to see if it can give some pocket money later ?.","images":[{"img":"https://static.tigerbbs.com/75b630e8fe686f7ea721fb05a07691e6","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/365052186","isVote":1,"tweetType":1,"viewCount":338,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":321427755,"gmtCreate":1615464741877,"gmtModify":1704783100189,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Likely","listText":"Likely","text":"Likely","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/321427755","repostId":"2118603672","repostType":4,"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329360014,"gmtCreate":1615209053338,"gmtModify":1704779567110,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Rocket to moon. ??️. Still holding on at $245. Not far not far away.&nbsp;","listText":"Rocket to moon. ??️. Still holding on at $245. Not far not far away.&nbsp;","text":"Rocket to moon. ??️. Still holding on at $245. Not far not far away.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329360014","repostId":"2117698552","repostType":2,"repost":{"id":"2117698552","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1615208520,"share":"https://ttm.financial/m/news/2117698552?lang=&edition=fundamental","pubTime":"2021-03-08 21:02","market":"hk","language":"en","title":"GameStop creates committee to identify way to accelerated transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=2117698552","media":"Dow Jones","summary":"MW GameStop creates committee to identify way to accelerated transformation\n\n\n \n\n\n$(END)$ Dow Jones ","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW GameStop creates committee to identify way to accelerated transformation\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  March 08, 2021 08:02 ET (13:02 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop creates committee to identify way to accelerated transformation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop creates committee to identify way to accelerated transformation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-08 21:02</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW GameStop creates committee to identify way to accelerated transformation\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  March 08, 2021 08:02 ET (13:02 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","TERN":"Terns Pharmaceuticals, Inc."},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117698552","content_text":"MW GameStop creates committee to identify way to accelerated transformation\n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  March 08, 2021 08:02 ET (13:02 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":34,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320956349,"gmtCreate":1615003603481,"gmtModify":1704778120139,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Good opportunity to enter","listText":"Good opportunity to enter","text":"Good opportunity to enter","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320956349","repostId":"1169596583","repostType":4,"repost":{"id":"1169596583","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1614958557,"share":"https://ttm.financial/m/news/1169596583?lang=&edition=fundamental","pubTime":"2021-03-05 23:35","market":"us","language":"en","title":"Palantir plunged more than 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169596583","media":"老虎资讯综合","summary":"(March 5)&nbsp;Palantir plunged more than 13%.","content":"<p>(March 5)&nbsp;Palantir plunged more than 13%.</p><p><img src=\"https://static.tigerbbs.com/13f756ec57cca85c31b6be070941d7c1\" tg-width=\"1059\" tg-height=\"499\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir plunged more than 13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir plunged more than 13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-05 23:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(March 5)&nbsp;Palantir plunged more than 13%.</p><p><img src=\"https://static.tigerbbs.com/13f756ec57cca85c31b6be070941d7c1\" tg-width=\"1059\" tg-height=\"499\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169596583","content_text":"(March 5) Palantir plunged more than 13%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":9,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362019196,"gmtCreate":1614572443715,"gmtModify":1704772562262,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Will be interesting to see how this change will play out and how it will change the landscape in future.&nbsp;","listText":"Will be interesting to see how this change will play out and how it will change the landscape in future.&nbsp;","text":"Will be interesting to see how this change will play out and how it will change the landscape in future.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/362019196","repostId":"2116168580","repostType":4,"repost":{"id":"2116168580","pubTimestamp":1614567899,"share":"https://ttm.financial/m/news/2116168580?lang=&edition=fundamental","pubTime":"2021-03-01 11:04","market":"sg","language":"en","title":"Hang Seng Index poised for biggest overhaul in 51 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2116168580","media":"The Straits Times","summary":"HONG KONG (BLOOMBERG) - Investors will soon discover if Hong Kong's Hang Seng Index will undertake o","content":"<div>\n<p>HONG KONG (BLOOMBERG) - Investors will soon discover if Hong Kong's Hang Seng Index will undertake one of the biggest overhauls in its 51-year history, a move that would impact tens of billions of ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/hang-seng-index-poised-for-biggest-overhaul-in-51-years\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hang Seng Index poised for biggest overhaul in 51 years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHang Seng Index poised for biggest overhaul in 51 years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-01 11:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/hang-seng-index-poised-for-biggest-overhaul-in-51-years><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HONG KONG (BLOOMBERG) - Investors will soon discover if Hong Kong's Hang Seng Index will undertake one of the biggest overhauls in its 51-year history, a move that would impact tens of billions of ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/hang-seng-index-poised-for-biggest-overhaul-in-51-years\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSI":"恒生指数"},"source_url":"http://www.straitstimes.com/business/companies-markets/hang-seng-index-poised-for-biggest-overhaul-in-51-years","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2116168580","content_text":"HONG KONG (BLOOMBERG) - Investors will soon discover if Hong Kong's Hang Seng Index will undertake one of the biggest overhauls in its 51-year history, a move that would impact tens of billions of dollars in funds tracking the stock benchmark.\nOn Monday (March 1), Hang Seng Indexes Co will offer its conclusion after an industry consultation over proposed changes to the city's stock benchmark, which if approved would increase the number of member constituents, cap weightings of individual companies and fast-track new listings. The announcement is expected shortly before a press briefing that starts at 4:30pm local time.\nThe city's stock market is already undergoing change at a time when China's tech giants hold growing sway, forcing the index compiler to act on a staid gauge overstuffed with banks and insurers. Hong Kong has become the preferred venue for a wave of Chinese megacaps to sell shares, including standouts like Kuaishou Technology, which surged 161 per cent at its debut in early February after holding the world's largest internet initial public offering since Uber Technologies.\nThe announcement will also come on the heels of a record buying frenzy from mainland traders that propelled the HSI past the 30,000 point level in January for the first time since May 2019, led by heavyweights like Tencent Holdings and Hong Kong Exchanges & Clearing. If the wide-ranging changes are approved, analysts say that the HSI, which in 2020 lagged global peers by the most in decades, could have more room to run.\n\"The valuation of the index will be pushed higher as more new economy stocks are expected to join under the changes,\" said Dickie Wong, executive director of research at Kingston Securities. \"This could also make the index more volatile.\"\nAs part of the proposed changes, Hang Seng Indexes is looking at ensuring that a certain number of benchmark members are classified as Hong Kong firms, which could dilute the influence of some of the largest stocks. The portion of mainland companies in the index by market value was 79 per cent in 2020, according to the December consultation paper.\nOn Friday, Hang Seng Indexes added three companies to its index following its quarterly review, expanding the constituent count to 55 members from 52. The changes are effective March 15. The benchmark index was 1.3 per cent higher as of 10.36am on Monday in Hong Kong, with Meituan and Tencent Holdings among leading gainers.\nLaunched in 1969, the Hang Seng Index started out with 33 constituents, rising to 38 in 2007 when it began to include H-share firms. Last year, Hang Seng Indexes added dual class shares and secondary listings to its index in a major revamp, allowing Chinese giants like Alibaba Group Holding Ltd. into the city's benchmark.\nKey changes under consideration\n• Increase the number of constituents to between 65 and 80, from 52 members\n• Remove minimum listing history requirement for inclusion into index. Currently, there is minimum three-month listing based on market value rank\n• Lower the weighting cap of individual constituents, now at 10 per cent, and align the weighting cap of secondary-listed members to 8 per cent\n• Select constituents by industry group to balance representation, Currently, among 12 industries, telecoms, financials and IT cover 80 per cent in terms of market capitalisation as of December 2020\n• Maintain a certain number of constituents classified as Hong Kong companies. The weighting of Hong Kong firms in HSI fell to 42.2 per cent in December 2020 from 45.3 per cent at end-2016","news_type":1},"isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325580292,"gmtCreate":1615906195216,"gmtModify":1704788328128,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher.&nbsp;","listText":"<a href=\"https://laohu8.com/S/KXIN\">$Kaixin Auto Group(KXIN)$</a>&nbsp;still holding on for higher.&nbsp;","text":"$Kaixin Auto Group(KXIN)$ still holding on for higher.","images":[{"img":"https://static.tigerbbs.com/320d3b07ffc6d1e3739c6ead11bb7833","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325580292","isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":322981458,"gmtCreate":1615767411774,"gmtModify":1704786160042,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"SNDL already up a fair bit.&nbsp;","listText":"SNDL already up a fair bit.&nbsp;","text":"SNDL already up a fair bit.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322981458","repostId":"1104628946","repostType":4,"repost":{"id":"1104628946","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615561247,"share":"https://ttm.financial/m/news/1104628946?lang=&edition=fundamental","pubTime":"2021-03-12 23:00","market":"us","language":"en","title":"Marijuana stocks fall","url":"https://stock-news.laohu8.com/highlight/detail?id=1104628946","media":"Tiger Newspress","summary":"Tilray Inc down 6%,Aphria,Canopy,Aurora,Sundial Growers and Cronos down 3%.","content":"<p>Tilray&nbsp;Inc&nbsp;down&nbsp;6%,Aphria,Canopy,Aurora,Sundial Growers and Cronos down 3%.</p><p><img src=\"https://static.tigerbbs.com/78fc26b0f02217c25526a73d40b1f353\" tg-width=\"420\" tg-height=\"414\" referrerpolicy=\"no-referrer\"></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Marijuana stocks fall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarijuana stocks fall\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-12 23:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tilray&nbsp;Inc&nbsp;down&nbsp;6%,Aphria,Canopy,Aurora,Sundial Growers and Cronos down 3%.</p><p><img src=\"https://static.tigerbbs.com/78fc26b0f02217c25526a73d40b1f353\" tg-width=\"420\" tg-height=\"414\" referrerpolicy=\"no-referrer\"></p><p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc.","CGC":"Canopy Growth Corporation","SNDL":"SNDL Inc.","APHA":"Aphria Inc.","CRON":"Cronos Group Inc.","ACB":"奥罗拉大麻公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104628946","content_text":"Tilray Inc down 6%,Aphria,Canopy,Aurora,Sundial Growers and Cronos down 3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328375207,"gmtCreate":1615503520809,"gmtModify":1704783680819,"author":{"id":"3577510395599113","authorId":"3577510395599113","name":"YOLO_HM","avatar":"https://static.tigerbbs.com/3e7bd84c2cc55c1d8baa7fd8df102a86","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577510395599113","authorIdStr":"3577510395599113"},"themes":[],"htmlText":"Closed below $50.&nbsp;","listText":"Closed below $50.&nbsp;","text":"Closed below $50.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328375207","repostId":"1117588517","repostType":4,"repost":{"id":"1117588517","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615483663,"share":"https://ttm.financial/m/news/1117588517?lang=&edition=fundamental","pubTime":"2021-03-12 01:27","market":"us","language":"en","title":"Coupang spikes 85% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1117588517","media":"Tiger Newspress","summary":"Coupang shares opened at $64.8 each on Thursday, about 85% higher than the company’s IPO price.Inves","content":"<p>Coupang shares opened at $64.8&nbsp;each on Thursday, about 85% higher than the company’s IPO price.</p><p><img src=\"https://static.tigerbbs.com/6d8a7bec648b4a2f82e6b4923e6d594e\" tg-width=\"1843\" tg-height=\"913\" referrerpolicy=\"no-referrer\"></p><p>Investors looking to buy shares of South Korean e-commerce firm&nbsp;Coupang&nbsp;when it goes public in New York should consider if the company has what it takes to be profitable in the future.</p><p>That’s the advice Daniel Yoo, head of global asset allocation at Yuanta Securities, Korea, has for clients.</p><p>“What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital,” Yoo said Thursday on CNBC’s “Street Signs Asia.”</p><p>Coupang is set to debut on the New York Stock Exchange under the ticker “CPNG” later in the day when U.S. markets open.</p><p>The company said it had&nbsp;priced 130 million shares at $35 apiece, raising $4.55 billion and valuing the company around $60 billion. That makes Coupang the largest IPO in the U.S. this year and one of the&nbsp;top 25 biggest listings of all time stateside, by deal size.</p><p>The price is also above the company’s most recent&nbsp;expected range&nbsp;of between $32 and $34 a share.</p><p><b>Market leader</b></p><p>Yoo explained that the valuation and IPO price likely rose because Coupang is the only e-commerce company in South Korea that showed a sizeable gain in market share last year. He said its market size rose from 18.1% in 2019 to about 24.6% last year due to the coronavirus pandemic.</p><p>“Most of the other competitors really did not show any type of changes in terms of market share,” he said. Coupang’s rivals include eBay-owned Gmarket, WeMakePrice, Naver Shopping among others.</p><p>“The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further,” Yoo said. “It is possible that they can actually gain as much as 30%+ over the next few years.” That, he explained, would justify why the company’s IPO price has increased.</p><p>Coupang’s regulatory filing showed the company sustained losses over eight quarters through Dec. 31. But a sharp jump in sales last year helped narrow net losses from $770.2 million in 2019 to $567.6 million in 2020</p><p><b>Comparisons with Alibaba, Amazon</b></p><p>The company, whose prominent backers include SoftBank’s Vision Fund and Sequoia Capital, has drawn comparisons with&nbsp;Amazon&nbsp;and&nbsp;Alibaba. Those firms have become tech behemoths after making their public debuts.</p><p>But Yoo said that the consumer markets in the U.S. and China are significantly larger than South Korea. So, even if Coupang is able to increase its market share, he said it is unlikely to see the same kind of sales growth the other two companies saw in the last decade.</p><p>South Korea’s e-commerce market has an estimated value of $90.1 billion in 2020 with an annual growth rate of 22.3%, according to&nbsp;data analytics firm GlobalData. That is expected to grow at a compounded annual rate of 12% to reach $141.8 billion in 2024.</p><p>Spending some of its IPO proceeds on building out a strong distribution platform within Korea could benefit Coupang, according to Yoo.</p><p>The e-commerce firm was founded by Korean-American billionaire Bom Suk Kim in 2010 and is headquartered in Seoul. It has more than 100 fulfilment and logistics centers in over 30 cities that provide next-day delivery for orders placed before midnight. Coupang employs 15,000 drivers in South Korea for its deliveries and has branched out into other services such as food and grocery delivery.</p><p></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coupang spikes 85% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoupang spikes 85% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-12 01:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Coupang shares opened at $64.8&nbsp;each on Thursday, about 85% higher than the company’s IPO price.</p><p><img src=\"https://static.tigerbbs.com/6d8a7bec648b4a2f82e6b4923e6d594e\" tg-width=\"1843\" tg-height=\"913\" referrerpolicy=\"no-referrer\"></p><p>Investors looking to buy shares of South Korean e-commerce firm&nbsp;Coupang&nbsp;when it goes public in New York should consider if the company has what it takes to be profitable in the future.</p><p>That’s the advice Daniel Yoo, head of global asset allocation at Yuanta Securities, Korea, has for clients.</p><p>“What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital,” Yoo said Thursday on CNBC’s “Street Signs Asia.”</p><p>Coupang is set to debut on the New York Stock Exchange under the ticker “CPNG” later in the day when U.S. markets open.</p><p>The company said it had&nbsp;priced 130 million shares at $35 apiece, raising $4.55 billion and valuing the company around $60 billion. That makes Coupang the largest IPO in the U.S. this year and one of the&nbsp;top 25 biggest listings of all time stateside, by deal size.</p><p>The price is also above the company’s most recent&nbsp;expected range&nbsp;of between $32 and $34 a share.</p><p><b>Market leader</b></p><p>Yoo explained that the valuation and IPO price likely rose because Coupang is the only e-commerce company in South Korea that showed a sizeable gain in market share last year. He said its market size rose from 18.1% in 2019 to about 24.6% last year due to the coronavirus pandemic.</p><p>“Most of the other competitors really did not show any type of changes in terms of market share,” he said. Coupang’s rivals include eBay-owned Gmarket, WeMakePrice, Naver Shopping among others.</p><p>“The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further,” Yoo said. “It is possible that they can actually gain as much as 30%+ over the next few years.” That, he explained, would justify why the company’s IPO price has increased.</p><p>Coupang’s regulatory filing showed the company sustained losses over eight quarters through Dec. 31. But a sharp jump in sales last year helped narrow net losses from $770.2 million in 2019 to $567.6 million in 2020</p><p><b>Comparisons with Alibaba, Amazon</b></p><p>The company, whose prominent backers include SoftBank’s Vision Fund and Sequoia Capital, has drawn comparisons with&nbsp;Amazon&nbsp;and&nbsp;Alibaba. Those firms have become tech behemoths after making their public debuts.</p><p>But Yoo said that the consumer markets in the U.S. and China are significantly larger than South Korea. So, even if Coupang is able to increase its market share, he said it is unlikely to see the same kind of sales growth the other two companies saw in the last decade.</p><p>South Korea’s e-commerce market has an estimated value of $90.1 billion in 2020 with an annual growth rate of 22.3%, according to&nbsp;data analytics firm GlobalData. That is expected to grow at a compounded annual rate of 12% to reach $141.8 billion in 2024.</p><p>Spending some of its IPO proceeds on building out a strong distribution platform within Korea could benefit Coupang, according to Yoo.</p><p>The e-commerce firm was founded by Korean-American billionaire Bom Suk Kim in 2010 and is headquartered in Seoul. It has more than 100 fulfilment and logistics centers in over 30 cities that provide next-day delivery for orders placed before midnight. Coupang employs 15,000 drivers in South Korea for its deliveries and has branched out into other services such as food and grocery delivery.</p><p></p><p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CPNG":"Coupang, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117588517","content_text":"Coupang shares opened at $64.8 each on Thursday, about 85% higher than the company’s IPO price.Investors looking to buy shares of South Korean e-commerce firm Coupang when it goes public in New York should consider if the company has what it takes to be profitable in the future.That’s the advice Daniel Yoo, head of global asset allocation at Yuanta Securities, Korea, has for clients.“What you really need to know is whether or not, in the business environment of Korea and e-commerce, can they be able to generate a huge, profitable return on capital,” Yoo said Thursday on CNBC’s “Street Signs Asia.”Coupang is set to debut on the New York Stock Exchange under the ticker “CPNG” later in the day when U.S. markets open.The company said it had priced 130 million shares at $35 apiece, raising $4.55 billion and valuing the company around $60 billion. That makes Coupang the largest IPO in the U.S. this year and one of the top 25 biggest listings of all time stateside, by deal size.The price is also above the company’s most recent expected range of between $32 and $34 a share.Market leaderYoo explained that the valuation and IPO price likely rose because Coupang is the only e-commerce company in South Korea that showed a sizeable gain in market share last year. He said its market size rose from 18.1% in 2019 to about 24.6% last year due to the coronavirus pandemic.“Most of the other competitors really did not show any type of changes in terms of market share,” he said. Coupang’s rivals include eBay-owned Gmarket, WeMakePrice, Naver Shopping among others.“The fact is that (Coupang is) becoming the biggest e-commerce business within Korea and 24% market share, I think, it might actually even rise further,” Yoo said. “It is possible that they can actually gain as much as 30%+ over the next few years.” That, he explained, would justify why the company’s IPO price has increased.Coupang’s regulatory filing showed the company sustained losses over eight quarters through Dec. 31. But a sharp jump in sales last year helped narrow net losses from $770.2 million in 2019 to $567.6 million in 2020Comparisons with Alibaba, AmazonThe company, whose prominent backers include SoftBank’s Vision Fund and Sequoia Capital, has drawn comparisons with Amazon and Alibaba. Those firms have become tech behemoths after making their public debuts.But Yoo said that the consumer markets in the U.S. and China are significantly larger than South Korea. So, even if Coupang is able to increase its market share, he said it is unlikely to see the same kind of sales growth the other two companies saw in the last decade.South Korea’s e-commerce market has an estimated value of $90.1 billion in 2020 with an annual growth rate of 22.3%, according to data analytics firm GlobalData. That is expected to grow at a compounded annual rate of 12% to reach $141.8 billion in 2024.Spending some of its IPO proceeds on building out a strong distribution platform within Korea could benefit Coupang, according to Yoo.The e-commerce firm was founded by Korean-American billionaire Bom Suk Kim in 2010 and is headquartered in Seoul. It has more than 100 fulfilment and logistics centers in over 30 cities that provide next-day delivery for orders placed before midnight. Coupang employs 15,000 drivers in South Korea for its deliveries and has branched out into other services such as food and grocery delivery.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}